rfhg_53652.1

Basic information about the TSS

---

TSS ID: rfhg_53652.1 Species: human Chr: chr3		Start: 184319617 End: 184319638 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS (EH38D3525754,EH38E2264313)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000484862.5:0 GeneID: 1981 HGNC/MGI_ID: HGNC:3296 UniProt_ID: Nearer transcript ids and distances: ENST00000676206.1:51 ENST00000441154.5:119 ENST00000444861.5:-418 AK308319:-418 view more...

Gene_name: eukaryotic translation initiation factor 4 gamma 1 Gene_symbol: EIF4G1 Gene_synonyms: PARK18 p220 Gene_source: HGNC:3296

TATA-Box annotation

---

Distance to TSS:	-636
Nearest PromoterID:	NM_004953
Entrez ID:	1981
Nearest Unigene:	Hs.433750
Nearest Refseq:	NM_004953
Nearest Ensembl:	ENSG00000114867
Gene Name:	eukaryotic translation initiation factor 4 gamma 1
Gene Alias:	EIF-4G1|EIF4F|EIF4G|EIF4GI|P220|PARK18
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.409091
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF4G1 p2@EIF4G1 p3@EIF4G1 p4@EIF4G1 p5@EIF4G1 p6@EIF4G1 p10@EIF4G1
Sample		p1@EIF4G1	p2@EIF4G1	p3@EIF4G1	p4@EIF4G1	p5@EIF4G1	p6@EIF4G1	p10@EIF4G1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	317.72	10.52	36.04	0.78	6.62	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	305.91	11.13	30.95	1.62	7.08	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	309.61	10.42	35.11	0.77	4.05	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	268.83	11.64	21.62	1.04	4.99	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	308.43	10.35	29.47	0.90	4.50	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	288.97	10.66	24.23	1.36	5.23	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	360.60	8.72	23.10	1.31	6.75	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	351.46	8.24	26.89	0.48	10.17	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	357.12	7.05	25.65	0.64	9.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	314.16	2.90	16.81	1.74	9.27	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	287.81	2.83	15.77	1.21	6.47	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	304.10	2.85	21.14	2.03	10.16	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	72.70	14.67	8.22	0.81	0.64	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	66.30	13.68	3.76	0.45	0.60	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	68.94	12.51	3.29	0.44	1.98	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	57.09	13.58	3.27	0.75	1.26	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	52.42	9.83	2.40	0.44	1.09	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	64.54	13.50	4.64	0.42	1.69	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	39.99	13.33	4.80	0.53	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	66.34	16.10	6.92	0.75	1.35	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	71.64	17.64	6.28	0.53	1.60	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	73.54	15.02	5.01	1.04	0.52	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	64.37	14.74	5.95	1.16	0.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	53.63	14.32	6.55	1.21	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	71.21	18.06	5.42	1.03	0.77	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	69.95	17.41	5.70	1.27	1.27	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	68.13	21.43	4.40	0.00	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	107.03	17.92	5.66	1.18	0.71	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	76.56	13.08	5.33	0.48	1.13	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	72.02	15.38	4.16	1.27	1.63	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	63.01	11.93	4.61	0.63	1.26	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	69.75	11.72	3.71	0.59	1.17	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	72.81	15.83	4.43	1.06	1.48	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	58.39	13.36	3.63	0.00	0.82	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	70.12	13.46	6.92	0.75	1.68	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	69.75	13.80	6.32	0.57	1.15	0.19	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	73.37	8.18	6.74	0.61	1.23	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	72.74	12.90	7.46	0.81	1.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	72.93	15.13	5.94	0.27	0.27	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	75.38	10.80	5.76	0.96	1.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	72.22	10.35	6.59	0.00	1.18	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	64.41	11.42	4.10	0.88	0.59	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	76.13	13.71	7.17	0.42	1.48	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	72.90	14.34	7.17	0.87	1.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	85.13	10.84	7.23	0.60	1.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	84.92	13.26	5.35	0.93	1.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	75.33	16.07	5.76	1.20	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	81.07	14.31	6.56	1.49	0.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	89.77	22.50	10.77	2.63	1.44	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	88.76	22.04	6.67	2.22	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	68.25	27.46	8.61	1.43	0.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	109.19	35.36	8.45	2.67	0.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	69.20	28.39	6.39	0.71	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	73.57	32.48	9.61	3.98	0.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	106.55	40.27	8.39	2.52	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	80.37	33.07	7.81	1.38	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	71.95	41.81	6.81	3.89	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	58.45	41.75	5.78	3.85	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	90.84	44.01	9.74	2.83	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	58.52	39.48	3.53	2.82	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	60.57	34.77	6.73	2.24	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	134.55	32.64	13.53	2.39	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	80.19	37.03	7.47	1.02	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	58.81	41.26	5.20	3.57	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	52.54	39.05	3.90	3.55	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	15.79	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	60.94	39.49	3.41	4.88	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	57.03	42.15	6.45	4.96	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	45.97	46.44	6.10	3.75	1.88	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	64.58	49.35	4.97	2.65	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	45.78	47.02	7.42	2.78	0.31	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	53.81	42.19	5.50	2.75	0.61	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	55.75	41.34	6.02	7.44	0.48	0.32	1.27
Adipocyte - breast, donor2	11327-117E4	81.18	46.36	9.47	9.14	1.44	0.96	1.93
Adipocyte - omental, donor1	11473-119C6	66.03	53.31	5.60	8.65	1.40	0.64	1.91
Adipocyte - omental, donor2	11474-119C7	46.34	36.63	11.96	8.97	0.00	0.00	2.99
Adipocyte - omental, donor3	11475-119C8	48.56	25.45	9.38	4.69	0.00	1.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	42.11	37.00	7.02	4.47	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	48.38	18.69	4.40	0.00	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	87.16	33.87	9.48	4.97	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	78.72	22.24	6.78	5.56	1.39	0.35	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	141.01	37.55	7.82	4.89	1.76	1.96	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	95.75	21.36	4.38	2.57	0.51	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	117.64	32.06	7.25	5.02	1.12	1.39	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	132.26	31.15	8.23	4.11	0.59	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	144.06	37.48	12.87	4.50	2.09	4.18	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	114.58	19.04	7.10	0.97	0.32	1.29	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	80.51	28.26	8.00	4.80	1.07	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	115.74	16.69	13.91	6.12	0.56	2.78	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	89.42	28.28	12.48	3.74	0.00	3.74	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	93.43	18.34	9.29	2.26	1.00	2.01	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	105.37	25.53	9.16	4.58	0.98	2.62	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	106.26	20.10	10.35	6.39	0.61	7.00	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	234.48	44.86	17.02	7.51	4.64	0.22	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	198.65	30.12	13.27	4.66	1.79	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	67.09	25.16	3.59	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	150.94	38.68	12.05	12.41	1.08	6.48	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	110.45	35.14	18.41	8.37	1.67	10.04	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	139.09	41.71	11.71	12.12	2.26	6.37	0.21
Anulus Pulposus Cell, donor1	11248-116E6	52.52	35.47	3.78	1.83	0.69	1.03	0.11
Anulus Pulposus Cell, donor2	11463-119B5	44.82	28.41	8.08	3.43	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	65.60	38.19	7.64	7.19	0.00	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	66.86	45.58	6.51	9.99	0.43	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	49.23	25.68	2.14	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	58.59	37.07	8.67	5.68	0.00	0.60	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	63.23	32.88	1.26	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.04	31.68	5.28	3.30	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	59.78	34.44	7.47	4.87	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	51.46	33.01	13.59	5.34	0.00	0.00	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.23	23.76	4.75	3.56	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	60.26	38.04	9.42	6.03	0.75	0.00	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	58.05	42.09	4.35	5.08	0.73	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	23.82	2.51	8.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.49	35.25	5.44	5.60	0.66	0.00	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	55.96	34.12	8.19	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	24.43	19.90	2.11	2.56	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	70.72	42.86	8.57	9.64	0.00	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	67.83	37.22	6.99	6.42	0.38	0.19	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	59.34	36.08	5.88	7.48	0.27	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	68.28	36.09	5.85	2.93	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	60.87	35.66	8.29	5.64	0.33	0.17	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	42.03	26.42	3.60	9.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	67.26	42.48	7.08	3.54	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	65.35	45.46	8.92	7.20	0.17	0.00	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	20.97	4.19	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	57.28	36.89	9.71	9.71	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	62.61	37.19	8.35	6.83	0.00	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	46.03	33.92	4.85	12.11	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	49.59	41.61	10.83	14.25	0.57	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	54.30	38.05	7.91	6.20	0.21	0.00	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	40.00	33.04	2.84	9.29	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	61.94	45.98	9.85	8.91	0.00	0.00	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	69.13	33.76	7.40	7.40	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	30.68	31.39	5.71	3.57	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	64.93	23.40	8.19	4.09	0.58	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	52.69	38.84	4.52	6.62	0.00	0.00	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	28.51	29.70	4.75	3.56	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	56.96	39.67	10.68	6.61	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	56.29	43.04	6.37	5.09	0.51	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	32.40	24.78	2.54	3.81	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	60.41	38.84	10.36	6.04	0.43	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	57.37	34.72	4.87	6.35	0.85	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	34.22	23.78	1.16	5.80	0.00	0.00	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	67.08	50.07	17.95	4.72	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	61.71	33.06	6.27	7.97	0.68	0.00	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	32.43	4.63	6.95	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	73.94	50.70	14.79	12.68	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	56.60	28.95	7.29	7.29	0.43	0.21	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	43.92	20.46	1.80	3.61	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	56.86	38.64	6.56	5.83	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	53.33	36.09	4.83	5.75	0.23	0.00	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	40.80	0.00	5.10	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.88	22.88	1.78	3.81	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	66.89	39.02	5.57	8.05	0.83	0.21	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	42.84	32.13	2.75	6.12	0.61	0.00	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	61.19	35.37	5.26	7.17	0.96	0.48	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	62.53	37.70	6.21	6.65	0.00	0.00	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	27.46	4.58	9.15	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	62.04	36.00	4.98	6.09	0.55	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	67.79	32.57	9.00	5.30	1.85	0.00	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	42.16	25.44	4.72	4.00	0.73	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	186.56	38.07	17.69	2.46	2.46	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	163.29	42.11	23.11	2.57	1.20	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	117.88	24.12	9.02	1.68	2.52	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	81.57	14.64	4.18	0.00	1.39	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	160.48	19.74	11.00	0.97	2.59	0.49	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	138.87	16.41	6.41	1.04	1.04	0.00	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	303.23	2.64	29.82	0.11	2.64	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	357.05	3.38	36.83	0.13	3.38	0.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	307.48	4.10	33.34	0.11	2.16	0.00	0.00
Basophils, donor1	12241-129G9	42.89	5.49	4.45	0.78	0.00	0.00	0.00
Basophils, donor2	12242-129H1	45.10	6.86	3.97	0.72	0.00	0.00	0.00
Basophils, donor3	12243-129H2	80.85	11.61	9.55	0.29	1.18	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	120.09	17.03	10.78	15.95	3.45	7.33	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	96.01	18.74	9.14	1.83	0.91	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	7.17	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	125.53	9.41	7.53	1.26	1.26	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	166.36	19.76	13.31	1.87	1.46	2.29	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	76.69	14.28	4.38	2.07	1.84	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	82.95	7.02	5.76	1.80	2.52	3.42	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	166.64	3.61	15.36	0.10	1.24	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	156.28	4.19	10.71	0.23	3.03	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	58.20	6.72	6.72	0.00	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	46.78	13.53	1.69	0.00	1.69	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	61.25	10.95	4.64	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	61.69	9.44	5.71	0.00	0.66	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	76.70	15.57	3.40	1.13	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	70.89	21.61	4.55	0.00	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	91.39	15.78	4.60	0.00	0.99	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	59.84	20.09	5.49	1.45	0.43	0.58	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	52.81	16.29	8.15	0.60	0.60	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	65.38	16.11	10.90	1.18	0.24	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	49.21	9.88	5.02	0.50	0.17	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	60.17	12.97	6.07	1.10	0.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	54.54	12.40	6.45	1.24	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	43.86	8.03	2.74	0.39	0.20	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	38.10	6.59	3.38	0.36	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	33.95	5.66	3.05	0.65	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	39.33	6.56	2.81	0.47	0.23	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	61.78	7.92	7.92	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	58.80	7.77	6.66	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	51.02	17.25	4.02	1.04	0.45	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	62.86	13.77	7.58	1.00	0.20	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	39.14	6.87	6.25	0.42	0.21	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	48.27	8.92	4.58	1.14	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	49.31	13.57	2.49	0.68	0.45	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	42.34	10.04	5.24	0.87	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	57.83	19.64	4.30	0.54	0.54	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	55.13	12.91	5.93	1.05	0.17	0.87	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	63.12	9.26	6.31	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	40.97	6.43	2.94	0.18	0.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	65.52	7.75	4.93	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	73.71	6.58	7.02	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	39.41	8.20	3.14	0.52	0.35	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	42.00	7.43	6.32	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	39.66	4.74	4.53	0.43	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	49.96	6.14	2.87	0.00	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	40.56	7.19	4.17	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	39.44	5.34	2.32	0.70	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	34.00	1.96	4.80	0.00	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	39.50	3.00	5.77	0.23	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	29.46	3.25	4.55	0.22	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	70.39	14.95	5.76	0.31	0.16	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	50.65	9.78	5.24	0.70	0.35	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	84.06	9.81	12.26	0.45	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	43.12	0.51	2.30	0.00	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	33.59	1.10	5.49	0.44	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	35.79	0.21	4.63	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	42.68	2.03	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	38.64	1.36	4.75	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	33.14	1.04	2.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	47.44	1.07	4.80	1.07	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	53.61	0.54	4.29	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	38.61	1.40	2.11	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	41.57	3.14	4.71	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	44.82	3.95	3.95	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	78.90	0.82	12.33	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	93.58	1.45	13.06	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	87.33	0.50	13.63	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	210.51	15.35	8.08	6.06	2.02	5.25	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	135.43	8.39	4.39	4.39	3.20	2.40	0.00
CD34+ Progenitors, donor1	11545-120B6	40.16	9.04	9.04	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	39.89	11.80	5.62	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	84.92	7.89	4.51	1.13	1.50	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	65.16	12.85	5.64	2.03	0.23	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	99.98	0.36	6.07	0.00	0.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	100.43	1.84	3.67	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	85.09	3.35	5.49	0.00	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	58.45	1.79	8.93	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	61.76	2.70	8.76	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	61.80	3.74	4.02	0.00	0.86	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	68.27	3.32	5.69	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	70.23	2.11	2.81	0.00	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	0.00	6.59	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	49.57	5.35	5.49	0.00	0.72	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	71.17	4.41	6.10	0.00	0.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	61.90	5.96	5.48	0.00	0.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	38.55	1.34	2.24	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	30.05	1.05	3.84	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	52.80	0.44	3.96	0.00	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	65.35	3.79	8.43	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	63.99	5.82	7.06	0.21	0.21	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.46	8.02	3.68	0.33	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	80.22	0.82	7.07	0.00	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	68.60	0.00	4.82	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	69.94	0.00	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	79.36	6.49	8.16	0.56	0.37	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.44	4.98	6.07	0.22	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	64.94	3.78	5.88	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	64.72	2.02	4.04	0.00	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	51.99	1.30	1.30	0.87	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	67.55	1.74	3.92	0.00	1.31	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	71.26	2.97	3.96	0.00	0.99	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	50.78	1.85	4.62	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	1.40	1.40	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	86.12	4.15	11.63	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	77.05	2.94	7.36	0.00	0.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	60.06	0.00	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	65.54	2.51	4.30	0.00	1.07	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	55.40	0.00	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	92.65	6.22	9.17	0.00	0.33	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	88.98	7.88	5.63	0.00	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	112.11	5.05	9.34	0.25	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	142.91	10.55	15.37	2.29	2.29	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	136.84	10.78	10.54	2.88	2.40	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	124.48	11.22	8.48	2.74	3.01	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	134.79	10.21	20.11	1.50	0.60	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	135.35	8.16	19.68	2.16	1.92	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	147.35	9.10	17.28	2.27	2.50	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	149.93	11.08	14.99	1.74	1.96	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	155.29	10.26	11.32	3.16	2.37	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	151.26	13.84	18.29	3.05	2.35	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	159.99	13.89	19.32	2.42	1.51	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	153.10	14.23	15.98	2.32	2.03	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	155.06	11.72	21.85	2.40	1.33	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	91.05	7.00	12.69	0.44	1.75	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	96.55	3.64	12.75	1.37	1.82	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	98.46	5.97	19.39	3.73	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	137.94	7.20	19.45	2.52	5.04	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	135.23	8.34	17.26	0.58	1.15	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	128.45	6.84	11.31	1.41	1.18	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	188.56	12.68	19.01	1.58	2.85	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	171.01	10.46	15.07	1.54	3.38	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	163.82	12.82	20.84	3.53	2.24	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	135.39	8.80	11.47	0.38	1.53	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	140.70	10.25	14.19	0.39	3.15	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	119.51	6.05	6.05	0.76	3.03	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	80.30	2.41	5.62	3.21	3.21	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	83.23	2.10	9.09	2.80	2.10	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	79.14	3.01	13.02	1.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	80.42	16.45	7.31	3.66	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	68.18	24.21	4.94	1.98	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	70.30	27.47	4.00	3.89	0.95	0.21	0.63
Chondrocyte - de diff, donor1	11261-116G1	66.21	44.37	7.28	10.40	0.69	0.35	0.69
Chondrocyte - de diff, donor2	11338-117F6	75.70	27.72	6.75	4.26	0.71	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	63.03	33.91	7.40	5.92	0.34	0.11	0.91
Chondrocyte - re diff, donor2	11339-117F7	124.44	19.70	12.53	3.58	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	65.51	16.58	7.68	3.24	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	89.97	9.18	7.23	0.57	1.26	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	91.28	14.11	8.55	0.86	1.50	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	107.79	19.38	11.77	1.95	0.97	0.18	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	110.22	28.43	10.91	3.85	1.65	2.02	0.37
Corneal Epithelial Cells, donor1	11526-119I5	153.70	19.98	11.64	2.63	2.20	3.07	0.00
Corneal Epithelial Cells, donor2	11606-120I4	162.68	13.65	19.34	6.83	2.28	9.10	2.28
Corneal Epithelial Cells, donor3	11687-122I4	158.75	9.46	13.29	5.88	3.32	6.39	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	68.18	25.26	9.08	7.10	0.83	1.82	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	75.07	24.60	6.31	5.99	0.63	1.26	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	20.70	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	79.80	16.63	11.77	2.38	0.11	2.16	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	71.06	6.15	11.96	0.00	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	64.63	7.18	7.83	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	58.07	3.87	8.23	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	127.75	55.37	7.34	7.67	1.67	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	76.28	33.45	8.21	7.04	0.00	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	154.97	102.09	10.75	13.86	1.41	0.28	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	91.61	57.40	5.50	11.40	0.79	0.00	2.36
Endothelial Cells - Artery, donor1	11264-116G4	136.13	99.48	13.67	14.83	1.45	0.00	1.75
Endothelial Cells - Artery, donor2	11341-117F9	162.58	96.93	8.71	16.94	0.71	0.00	0.94
Endothelial Cells - Artery, donor3	11413-118E9	158.30	69.25	11.22	13.85	1.05	0.00	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	61.84	69.38	3.10	11.53	0.66	0.00	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	70.29	71.20	7.30	14.30	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	86.83	71.89	7.61	11.84	0.56	0.00	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	80.23	52.00	9.51	6.54	1.49	0.00	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	70.81	38.53	4.69	9.37	2.08	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	67.21	60.97	6.24	11.20	0.85	0.14	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	170.85	82.42	14.00	13.20	0.40	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	99.58	87.53	9.43	8.39	0.00	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	161.89	76.29	5.96	8.57	2.48	0.12	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	139.26	52.36	9.34	7.82	2.17	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	219.34	59.60	12.46	8.18	3.05	0.00	0.61
Endothelial Cells - Vein, donor1	11267-116G7	117.16	50.05	17.06	11.38	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	127.83	53.09	13.27	6.99	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	105.67	56.84	7.22	6.28	0.63	0.00	0.47
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	62.71	3.30	4.95	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	53.50	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	126.32	19.30	9.77	4.40	0.73	2.20	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	76.97	14.56	8.32	8.32	2.08	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	16.27	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	58.70	55.42	2.87	18.88	0.00	0.00	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	43.03	34.71	3.61	6.79	0.44	0.22	1.53
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.08	39.54	1.30	10.51	0.76	0.54	2.06
Fibroblast - Aortic Adventitial, donor1	11245-116E3	99.45	58.58	4.97	8.25	1.70	0.24	2.30
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	139.20	70.56	16.51	14.33	1.36	0.82	2.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	81.00	63.49	7.07	12.97	1.05	0.53	2.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	243.47	54.28	44.00	21.08	1.58	2.37	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	122.58	52.16	8.97	15.28	1.00	0.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	102.97	53.53	7.71	10.89	0.91	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	115.21	84.89	11.37	12.89	2.27	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	93.05	63.72	6.47	10.25	1.42	0.16	2.21
Fibroblast - Cardiac, donor4	11452-119A3	132.15	60.32	9.40	11.52	0.91	1.21	0.91
Fibroblast - Cardiac, donor5	11456-119A7	85.79	41.50	6.98	3.81	0.63	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	114.15	36.53	7.28	7.43	1.06	0.15	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	100.09	48.64	15.14	4.56	0.67	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	75.50	38.40	11.22	1.29	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	128.90	19.04	10.25	0.00	4.39	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	265.00	35.29	9.69	3.46	6.23	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	57.16	50.71	3.73	8.14	0.17	0.17	1.02
Fibroblast - Dermal, donor1	11269-116G9	101.90	39.44	10.80	6.34	1.17	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	133.96	37.73	8.49	5.19	1.89	0.00	1.89
Fibroblast - Dermal, donor3	11418-118F5	85.71	34.82	5.32	5.20	2.18	0.12	1.09
Fibroblast - Dermal, donor4	11450-119A1	134.52	20.46	14.36	0.57	1.47	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	152.65	25.47	16.05	1.22	1.92	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	172.66	28.26	19.49	0.81	0.81	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	98.49	61.84	8.33	6.66	1.25	1.67	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	112.14	80.17	8.38	19.13	0.26	1.31	2.88
Fibroblast - Gingival, donor2	11318-117D4	126.25	30.57	5.53	2.90	1.58	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	108.39	65.55	7.64	6.38	1.26	0.87	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	84.15	47.79	6.23	10.39	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	78.94	40.35	5.46	6.52	1.59	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	176.32	67.50	11.07	9.82	2.65	1.09	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	123.06	60.31	10.41	9.06	1.35	0.95	1.62
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	450.27	182.79	38.82	31.41	4.23	1.41	6.70
Fibroblast - Gingival, donor7 (control)	11924-125H7	130.01	69.32	13.45	11.55	2.05	0.88	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	137.44	73.49	12.14	12.14	1.77	1.36	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	211.38	61.54	13.05	17.11	3.84	0.22	1.76
Fibroblast - Gingival, donor9 (control)	11927-125I1	77.62	58.40	6.75	10.86	1.17	1.03	1.32
Fibroblast - Lung, donor1	11270-116H1	87.00	46.22	9.52	5.44	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	113.40	23.87	4.48	7.46	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	111.22	43.47	5.91	4.64	1.48	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	308.22	131.62	33.32	19.99	2.50	5.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	118.88	82.52	15.38	19.58	1.40	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	81.72	68.57	8.12	7.56	1.12	0.56	0.28
Fibroblast - Mammary, donor1	11540-120B1	388.92	146.55	36.94	9.74	2.84	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	183.73	67.90	23.97	7.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	131.04	101.26	29.78	29.78	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	120.85	30.65	7.56	2.52	1.36	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	219.94	43.68	13.50	2.58	3.19	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	205.32	93.94	14.99	13.77	1.84	1.53	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	120.97	60.30	12.59	9.92	1.14	1.14	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	88.56	57.78	4.59	12.15	0.81	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	91.16	36.76	8.12	10.79	1.04	0.35	1.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	80.69	37.80	4.09	5.53	1.44	0.00	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	272.28	86.36	23.98	8.53	2.84	1.83	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	163.71	58.13	16.71	4.68	1.34	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	68.40	30.84	4.74	3.95	1.19	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	427.65	83.15	57.75	17.66	3.57	0.40	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	58.97	23.45	6.93	3.91	0.89	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	72.92	31.73	5.91	6.31	0.99	0.20	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	270.47	54.45	47.84	13.84	0.60	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	88.95	52.14	10.47	7.34	0.76	0.32	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	217.39	67.82	39.99	12.15	1.01	1.77	1.27
Fibroblast - skin normal, donor1	11553-120C5	70.55	43.48	6.40	8.37	0.66	0.33	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	317.00	91.83	26.67	18.85	2.81	1.00	3.21
Fibroblast - skin normal, donor2	11561-120D4	86.30	53.85	10.55	11.55	1.21	0.10	2.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	334.58	77.37	51.08	17.23	1.81	1.81	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	64.79	37.53	3.98	4.39	0.66	0.25	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	67.01	46.33	10.43	12.14	0.34	1.54	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	202.97	53.86	39.74	15.44	0.33	0.99	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	92.67	42.40	10.76	9.05	1.07	0.43	1.70
Fibroblast - skin walker warburg, donor1	11554-120C6	108.46	35.59	10.80	7.08	1.18	1.18	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.21	30.11	2.04	3.76	0.00	0.47	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	109.81	20.05	5.23	17.43	0.00	10.46	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	100.72	33.11	9.53	2.77	1.56	1.91	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	127.52	42.68	9.63	4.42	1.30	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	160.21	39.35	13.29	4.34	1.02	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	113.30	8.42	3.83	1.53	3.06	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	128.89	10.85	7.66	0.00	3.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	165.17	0.86	5.71	0.00	2.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	121.88	2.76	6.62	0.28	2.48	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	126.04	3.88	5.71	0.46	2.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	172.77	2.77	7.73	0.20	1.39	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	122.65	2.64	4.49	0.00	1.59	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	118.39	5.54	5.54	0.33	0.98	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	141.95	1.77	5.31	0.00	1.77	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	151.07	2.83	9.33	0.71	2.69	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	152.57	4.56	12.56	0.74	2.83	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	181.05	4.30	9.40	0.00	2.95	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	152.02	5.20	9.54	0.25	2.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	167.36	5.68	8.03	0.14	2.63	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	152.07	7.73	6.71	1.42	2.24	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	115.91	8.90	6.39	0.91	2.28	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	115.60	10.59	8.10	0.75	3.11	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	133.55	13.77	6.12	1.31	3.72	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	112.87	7.68	7.39	0.30	1.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	132.41	4.13	9.70	0.00	1.43	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	132.93	10.05	11.39	0.22	2.01	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	124.00	8.47	11.09	0.40	1.01	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	117.39	5.43	14.42	0.34	1.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	155.09	13.21	9.22	1.60	2.39	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	155.15	9.16	11.34	0.10	0.94	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	142.94	7.17	16.39	0.17	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	113.86	4.98	14.27	0.44	1.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	117.39	9.57	10.40	1.16	1.66	0.08	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	124.96	8.98	12.25	2.04	1.43	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	95.31	7.22	9.90	0.62	1.03	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	108.49	5.30	11.88	0.00	0.92	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	132.08	4.67	11.01	0.33	1.67	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	97.21	5.73	7.94	0.00	1.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	104.17	4.67	14.51	0.00	0.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	131.78	9.89	14.10	0.81	0.65	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	89.16	3.85	8.66	0.00	0.96	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	96.93	5.02	12.60	0.19	0.38	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	127.96	4.59	11.23	0.47	1.11	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	104.91	8.51	6.99	0.30	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	111.65	7.53	16.94	0.10	1.05	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	108.68	5.71	10.32	0.66	0.88	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	95.95	10.94	11.50	0.00	0.56	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	101.29	10.55	17.22	0.56	0.93	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	110.44	13.64	10.16	0.53	1.60	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	154.99	12.09	14.08	0.46	1.53	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	116.71	12.57	13.86	0.78	0.78	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	131.20	14.91	13.01	1.90	1.36	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	114.48	17.88	10.51	0.55	0.55	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	102.20	21.27	13.16	1.10	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	187.44	31.74	26.78	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	111.99	30.34	11.34	1.58	1.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	81.31	26.03	7.06	1.61	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	216.80	51.34	29.48	3.30	1.27	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	189.31	4.98	10.35	0.20	1.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	164.09	2.93	10.32	0.15	3.08	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	198.24	2.86	13.30	0.41	3.07	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	94.82	2.19	5.32	0.31	1.25	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	80.53	2.54	3.67	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	145.74	2.31	8.30	0.46	3.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	123.74	2.47	17.32	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	166.33	6.19	11.99	1.16	2.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	152.42	0.00	11.23	3.21	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	111.29	3.48	10.43	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	115.55	4.23	12.37	0.65	2.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	135.07	7.82	7.82	0.00	1.65	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	3.33	10.00	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	117.17	4.47	7.55	0.00	1.12	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	119.95	6.54	9.15	0.00	1.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	105.69	3.36	1.68	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	114.51	4.13	6.68	0.32	1.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	110.39	5.09	8.49	0.34	1.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	79.35	2.09	6.26	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	138.59	2.86	10.31	0.00	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	100.04	3.55	6.81	0.00	0.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	74.54	6.78	5.08	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	138.35	11.60	14.08	0.83	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	142.22	4.83	9.90	0.23	2.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	10.54	10.54	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	92.26	7.30	8.07	0.38	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	82.80	5.87	8.15	0.65	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.14	2.01	4.01	0.67	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	109.03	5.01	8.86	0.00	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	171.85	18.14	10.95	2.40	1.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	2.48	17.39	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	79.74	1.89	6.13	0.00	1.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	81.47	0.60	6.03	0.00	1.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	78.84	4.07	10.17	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	85.75	4.79	6.78	0.00	0.80	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	77.95	2.96	7.89	0.00	0.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	70.83	3.54	8.26	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	64.76	1.75	5.83	0.00	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.83	3.95	6.14	0.00	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	92.40	4.24	7.63	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	61.48	3.58	8.36	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	65.99	6.31	11.16	0.49	1.46	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	101.58	34.24	7.99	3.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	112.27	38.67	7.07	6.24	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	78.71	48.35	12.37	5.62	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	75.48	46.62	8.25	6.98	0.95	0.95	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	42.61	31.33	3.76	7.10	1.25	2.51	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	131.36	6.27	12.18	0.35	3.02	0.93	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	159.52	6.75	17.22	0.34	3.71	1.52	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	141.51	4.10	18.66	0.00	4.78	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	134.45	5.79	11.37	0.55	2.40	1.09	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	153.23	7.74	14.83	0.86	2.15	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	145.32	5.60	11.84	0.86	0.86	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	112.21	7.60	10.96	0.87	2.37	0.87	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	105.33	6.00	11.67	0.86	1.54	0.69	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	98.35	4.49	15.06	0.96	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	105.77	40.29	10.63	5.04	1.12	0.00	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	172.68	56.70	12.55	5.19	3.03	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	103.11	81.96	5.29	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	138.27	84.30	18.69	7.41	2.82	0.35	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	118.42	77.74	10.90	7.27	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	125.01	33.39	7.87	8.22	1.75	0.17	0.70
Hepatocyte, donor1	11523-119I2	181.59	102.90	8.47	10.90	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	251.02	118.51	23.70	5.39	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	236.21	68.10	14.72	9.82	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	83.54	0.65	3.92	0.00	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	124.27	6.29	7.52	0.17	1.75	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	92.20	20.99	8.64	0.82	1.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	222.87	9.55	19.10	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	213.61	0.00	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	297.92	0.00	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	168.89	5.54	27.69	0.00	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	112.62	5.01	15.02	0.00	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	296.71	0.00	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	189.66	5.13	28.19	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	82.27	4.57	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	255.02	4.87	16.24	0.00	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	188.41	10.00	16.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	83.50	7.26	10.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	211.76	3.97	19.85	1.32	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	181.82	4.43	19.96	1.11	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	110.00	10.48	15.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	136.05	1.26	13.86	0.00	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	202.61	4.64	18.56	0.00	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	146.35	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	184.12	2.58	22.61	0.65	2.58	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	217.34	4.83	30.59	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	23.90	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	187.42	0.81	31.78	0.00	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	183.46	5.88	20.99	0.00	2.94	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	182.44	2.41	14.47	0.00	4.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	204.97	6.46	25.85	0.00	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	136.89	0.94	14.16	0.00	2.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	170.51	3.63	32.65	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	147.42	0.00	14.74	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	163.57	5.38	23.67	0.00	5.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	228.68	5.08	20.33	0.00	5.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	188.75	3.19	30.61	0.00	3.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	195.02	1.82	49.21	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	199.94	4.28	24.99	0.00	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	205.74	0.00	43.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	41.70	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	152.79	4.32	18.83	0.00	0.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	244.09	5.27	29.85	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	194.87	6.29	40.86	0.00	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	207.92	5.56	25.03	0.00	2.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	141.64	6.64	11.07	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	171.83	3.24	29.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	132.53	1.74	12.21	1.74	3.49	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	83.24	6.75	13.50	0.00	6.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	160.29	3.48	34.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	100.28	4.27	7.47	0.00	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	198.12	4.16	37.41	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	193.77	2.85	28.50	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	164.76	3.68	23.93	0.00	5.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	114.96	3.03	12.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	0.00	24.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	104.68	1.06	4.23	0.00	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	161.24	31.01	8.08	4.90	3.92	3.51	0.57
Keratinocyte - epidermal, donor2	11349-117G8	95.46	17.57	3.51	2.34	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	164.04	19.69	10.51	1.99	2.84	1.89	0.47
Keratinocyte - oral, donor1	11251-116E9	134.75	15.44	6.02	2.27	3.06	5.34	0.00
Keratocytes, donor1	11527-119I6	284.35	29.23	7.22	1.72	4.81	0.00	0.00
Keratocytes, donor2	11607-120I5	144.13	52.73	12.89	8.20	3.52	1.17	1.17
Keratocytes, donor3	11688-122I5	127.05	23.12	3.16	5.34	1.38	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	353.86	4.40	41.76	0.00	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	125.13	23.73	6.47	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	72.66	7.15	6.11	0.00	0.81	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	122.30	41.78	8.68	4.94	1.92	0.20	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	81.23	34.86	3.91	3.79	0.71	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	56.09	25.95	3.35	1.67	0.56	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	62.49	28.65	3.78	2.52	0.79	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	65.60	25.81	2.69	3.76	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	78.79	29.94	4.73	2.84	1.26	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	67.71	28.36	3.99	4.20	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	64.02	21.75	3.69	4.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	57.39	21.24	3.29	2.78	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	70.66	31.95	4.08	2.96	0.99	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	60.52	29.27	3.56	5.54	1.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	64.18	22.68	3.10	2.33	0.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	60.36	21.85	2.78	3.52	0.74	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	69.34	30.66	5.57	6.97	1.05	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	65.83	25.04	2.39	1.91	1.19	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	72.25	30.49	4.53	3.16	0.96	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	61.90	28.95	5.24	2.77	1.85	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	58.92	26.81	3.74	2.81	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	93.69	34.22	4.94	4.57	0.91	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	64.51	25.67	6.25	4.28	1.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	64.14	25.77	4.10	2.64	0.59	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	81.15	35.10	5.73	3.73	1.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	65.96	32.01	8.73	3.88	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	56.55	24.24	2.42	2.42	0.54	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	76.29	31.49	4.39	5.15	0.76	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	55.99	19.70	4.67	1.04	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	61.77	23.45	3.14	2.30	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	75.64	29.62	6.77	2.86	0.75	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	74.29	30.95	7.57	7.57	0.00	0.00	4.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	58.89	27.28	2.26	4.14	1.13	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	71.46	27.89	3.61	4.03	0.32	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	62.03	40.22	3.88	3.39	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	61.86	18.85	2.65	2.98	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	70.99	32.71	2.97	3.96	0.74	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	67.75	35.91	2.96	4.44	1.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	47.44	22.48	1.73	1.73	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	62.83	27.64	3.30	4.54	0.55	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	65.61	30.23	3.54	4.82	1.93	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	62.39	27.39	3.04	3.96	0.91	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	66.06	30.37	4.20	3.78	0.42	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	66.85	22.04	6.04	3.20	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	56.72	21.33	2.91	4.36	0.48	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	70.02	30.34	4.05	2.96	0.31	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	62.31	35.81	4.30	5.73	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	78.40	30.38	3.27	3.27	0.33	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	65.45	24.01	3.06	2.12	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	94.05	42.32	4.70	6.93	1.11	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	54.04	18.44	3.84	3.07	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	69.22	23.57	7.16	1.49	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	0.00	4.53	4.53	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	115.84	7.67	22.25	1.53	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	115.79	6.68	17.81	0.74	2.97	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	116.78	6.77	12.27	2.96	2.12	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	109.02	4.92	11.96	1.41	2.11	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	110.21	8.41	14.94	1.87	0.00	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	99.96	7.73	11.85	2.06	0.00	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	117.76	2.38	14.27	2.38	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	82.11	7.69	7.69	1.58	2.04	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	89.28	8.14	10.18	1.74	1.16	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	119.75	10.35	14.86	2.70	0.90	2.25	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	135.21	14.23	12.46	4.47	2.57	2.17	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	105.27	8.22	8.22	2.05	2.57	2.05	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	113.27	4.94	17.64	2.47	0.71	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	95.95	4.66	14.66	1.33	1.33	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	111.56	9.68	18.34	3.06	1.02	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	131.00	6.67	12.54	3.20	1.33	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	136.61	7.37	14.55	2.83	1.89	2.08	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	96.94	9.82	14.11	6.14	0.61	1.84	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	150.85	14.68	17.94	3.26	4.08	4.89	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	126.40	8.12	13.54	2.71	2.71	1.46	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	106.50	6.17	11.49	2.80	1.12	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	127.76	3.09	19.58	5.15	2.06	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	131.51	12.19	15.10	2.90	2.32	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	88.48	8.07	9.86	2.39	0.60	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	126.14	6.09	17.70	4.43	2.77	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	163.31	9.19	21.21	2.12	1.77	3.53	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	109.53	8.85	11.43	4.06	2.21	2.21	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	103.61	10.36	10.36	2.30	1.15	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	137.38	10.75	16.89	2.30	2.69	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	108.13	9.06	11.89	1.70	2.26	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	131.27	9.85	18.05	4.10	4.10	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	124.72	11.30	10.39	4.52	3.16	1.81	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	102.69	7.18	11.49	3.59	1.44	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	150.13	6.72	19.42	1.49	2.99	2.99	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	137.86	8.18	11.52	2.97	2.60	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	105.10	9.91	6.46	2.58	1.72	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	137.86	9.42	21.41	4.28	2.57	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	152.26	9.33	10.00	3.33	1.67	3.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	116.44	9.05	12.67	2.41	0.00	1.81	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	121.58	7.82	14.93	4.27	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	150.55	9.28	13.75	3.09	1.72	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	95.54	8.59	11.27	2.68	1.07	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	121.88	13.47	12.12	1.35	0.67	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	161.13	11.85	10.74	2.59	1.85	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	65.12	9.30	5.81	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	96.25	11.64	17.98	3.17	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	153.26	11.60	19.21	3.20	1.60	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	101.04	6.54	10.18	1.45	1.45	2.18	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	134.14	5.37	13.80	2.30	4.60	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	121.84	13.32	14.31	1.97	2.96	1.97	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	90.33	10.35	13.17	3.76	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	128.72	8.55	20.62	2.51	3.52	2.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	144.65	8.56	19.38	1.80	2.25	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	96.38	6.88	5.16	5.16	1.72	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	143.85	11.58	21.38	3.12	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	149.37	12.51	18.38	3.91	2.74	1.56	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	108.20	5.94	11.22	1.98	1.32	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	132.84	11.94	14.53	5.19	1.04	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	148.34	7.44	11.38	4.38	3.50	3.06	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	111.82	10.62	11.74	5.03	0.56	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	128.08	7.95	18.99	3.09	4.42	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	128.83	12.73	13.89	5.01	2.70	2.70	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	101.78	8.61	7.60	2.03	2.53	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	123.52	12.02	17.78	1.92	2.88	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	166.17	10.34	12.72	5.17	1.99	1.99	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	121.52	5.47	10.94	6.08	1.22	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	105.14	8.30	17.29	2.08	0.00	3.46	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	158.08	12.16	15.96	4.94	1.90	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	108.96	11.88	13.94	2.58	1.55	2.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	108.84	13.30	21.77	9.07	2.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	138.17	9.51	11.09	5.39	2.85	2.85	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	103.42	14.93	15.46	4.80	0.53	2.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	90.22	7.47	14.37	4.02	1.15	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	172.27	14.40	12.86	5.66	2.57	3.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	109.64	8.49	11.32	4.24	0.71	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	125.41	7.38	17.02	3.40	0.57	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	168.07	7.90	16.22	3.74	2.91	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	119.02	7.05	13.31	4.70	0.78	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	111.90	11.69	12.94	4.59	1.67	1.67	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	140.79	13.01	11.62	1.86	1.39	3.25	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	111.06	10.04	14.72	4.01	2.01	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	129.38	16.04	14.44	4.81	3.21	2.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	158.41	12.53	11.31	6.47	2.42	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	109.21	13.77	7.34	5.51	1.84	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	142.26	14.23	14.23	4.45	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	184.64	16.53	21.09	5.13	5.70	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	121.94	13.04	9.97	6.90	3.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	133.51	14.77	13.68	6.02	3.28	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	171.94	13.36	16.48	4.01	3.56	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	142.46	13.26	9.88	3.64	3.38	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	111.40	13.93	17.24	3.98	1.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	203.70	12.47	20.79	8.31	2.08	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	60.17	15.95	8.20	0.68	0.23	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	93.04	16.70	8.26	0.73	1.10	3.49	0.18
Macrophage - monocyte derived, donor3	11389-118C3	101.85	17.17	10.49	1.44	0.92	2.10	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	46.73	20.18	4.78	2.12	0.53	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	115.83	56.57	12.20	6.18	0.48	0.79	0.32
Mallassez-derived cells, donor3	11930-125I4	118.97	34.47	13.90	3.20	0.83	0.14	0.83
Mammary Epithelial Cell, donor1	11273-116H4	109.71	34.78	4.48	5.18	4.48	0.50	0.70
Mammary Epithelial Cell, donor2	11350-117G9	133.19	19.69	10.42	3.19	1.45	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	145.42	17.21	11.22	3.24	2.00	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	113.89	46.10	6.78	8.14	1.36	0.68	2.71
Mast cell, donor1	11563-120D6	96.68	10.81	9.62	1.19	0.97	0.43	0.00
Mast cell, donor2	11565-120D8	146.21	13.37	11.29	1.49	1.49	0.00	0.30
Mast cell, donor3	11566-120D9	167.49	9.23	4.73	0.45	2.70	0.45	0.00
Mast cell, donor4	11567-120E1	158.14	11.17	7.09	0.89	1.95	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	101.13	11.42	11.42	0.22	0.89	0.33	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	91.05	63.62	8.17	5.25	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	66.08	8.26	6.19	0.23	0.11	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	60.92	12.05	9.71	0.17	0.33	0.00	0.50
Melanocyte - dark, donor1	11502-119F8	67.56	27.76	3.18	2.29	0.70	0.10	0.30
Melanocyte - dark, donor2	11582-120F7	74.75	32.53	10.04	3.11	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	152.56	5.51	12.68	0.80	0.94	0.00	0.00
Melanocyte - light, donor1	11274-116H5	133.52	10.58	10.58	0.71	0.47	0.00	0.00
Melanocyte - light, donor2	11351-117H1	107.15	7.51	10.92	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	97.13	12.14	10.41	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	161.60	5.52	16.04	0.62	1.15	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	116.72	9.95	6.19	0.81	1.34	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	152.41	9.91	19.29	0.27	0.54	0.00	0.00
Meningeal Cells, donor1	11493-119E8	279.63	55.45	36.85	4.59	2.85	0.00	0.25
Meningeal Cells, donor2	11573-120E7	190.14	29.05	28.17	4.40	2.20	0.00	0.44
Meningeal Cells, donor3	11654-122E7	169.03	29.75	10.11	2.85	2.28	0.08	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	85.83	24.52	3.42	0.86	1.14	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	57.76	32.30	4.13	5.94	0.91	0.00	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	67.02	51.25	5.26	18.40	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	137.36	35.32	9.16	5.23	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	127.02	43.06	8.61	5.02	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	69.67	19.27	8.68	1.91	0.85	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	74.39	22.62	6.03	6.53	1.01	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	188.55	41.53	19.34	4.40	3.96	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	193.61	42.37	19.00	3.65	3.65	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	172.68	41.13	18.21	4.71	2.46	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	52.22	33.38	5.54	4.29	0.55	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	122.30	49.81	7.06	9.29	0.74	0.37	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	68.16	36.31	3.42	4.08	0.79	0.39	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	81.60	48.37	10.39	3.86	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	35.03	7.01	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	158.82	30.10	12.81	6.40	2.56	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	111.65	32.61	7.44	3.90	0.71	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	58.17	28.77	1.56	3.44	0.31	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	137.88	10.16	8.71	0.00	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	83.00	53.83	5.04	6.63	1.86	1.59	0.00
Mesothelial Cells, donor2	12156-128G5	72.07	50.55	3.50	10.01	1.50	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	108.61	69.37	11.13	8.17	1.37	1.01	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	140.43	29.71	8.10	5.40	0.00	6.75	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	123.63	25.86	15.76	3.20	1.23	6.65	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	125.73	23.56	11.48	0.88	0.29	9.13	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	107.17	13.83	3.46	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	69.12	14.57	7.44	1.55	0.31	3.72	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	92.93	20.54	6.43	1.04	1.04	5.81	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	83.38	18.53	2.32	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	103.86	26.78	14.01	1.25	0.25	9.01	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	140.11	26.07	10.71	1.86	1.40	10.71	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	87.38	18.49	9.35	1.63	0.81	4.88	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	110.47	20.59	12.27	1.19	1.58	7.92	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	25.65	8.55	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	69.91	23.01	4.42	0.00	0.00	5.31	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	91.56	19.00	7.22	2.66	1.52	7.22	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	56.58	1.32	1.32	0.00	5.26	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	70.25	16.55	8.06	1.27	0.00	4.24	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	96.69	13.81	9.21	0.00	0.00	7.37	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	80.77	17.88	10.43	1.19	0.60	3.58	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	167.67	10.06	8.38	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	63.48	17.31	7.03	0.75	0.50	2.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	94.12	19.01	6.18	1.66	0.24	6.89	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	63.58	11.06	3.87	0.55	1.11	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	69.30	18.88	7.37	2.07	0.23	3.45	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	82.45	17.04	9.89	0.63	1.05	5.68	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	78.27	17.73	11.21	0.82	0.41	2.65	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	62.22	15.88	7.72	1.07	0.00	4.29	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	102.70	20.90	8.89	1.11	1.11	6.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	175.41	10.32	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	60.89	18.18	8.98	0.66	0.00	4.82	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	99.87	21.80	9.13	2.03	1.01	4.56	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	61.31	6.63	4.97	1.66	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	73.66	20.66	8.15	1.36	0.82	3.26	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	106.75	24.41	6.76	1.76	0.88	5.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	73.05	13.08	2.18	2.18	2.18	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	52.38	20.66	6.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	78.44	20.41	8.40	1.20	0.80	4.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	120.67	9.60	6.86	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	69.58	24.03	6.51	0.50	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	126.39	8.15	18.35	6.12	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	73.57	15.33	4.38	0.88	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	94.91	12.14	14.35	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	118.47	10.25	7.68	0.64	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	92.23	18.59	10.41	0.99	1.24	2.23	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	79.33	11.83	6.96	2.78	0.00	2.78	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	165.74	17.68	19.89	2.21	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	84.10	15.38	9.57	2.05	0.34	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	120.78	17.50	10.94	0.44	0.44	2.63	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	112.92	7.46	17.75	1.78	2.13	1.42	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	79.40	12.62	9.82	0.56	0.28	2.24	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	79.38	13.72	8.31	0.42	0.42	2.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	96.74	7.58	15.15	0.00	0.00	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	98.64	11.46	13.57	0.00	0.60	2.41	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	90.16	17.11	11.27	1.25	0.83	2.92	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	137.16	7.22	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	72.96	11.08	10.16	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	101.87	13.09	18.78	1.71	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	93.69	9.95	12.44	0.83	0.97	1.93	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	83.45	9.85	10.11	1.04	0.00	1.04	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	120.54	15.87	18.45	1.29	0.43	3.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	79.40	8.26	2.54	0.00	0.64	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	80.60	8.27	12.81	0.80	0.53	1.33	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	108.36	18.86	15.86	0.60	0.30	6.88	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	83.34	9.75	11.72	0.42	0.99	1.41	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	72.30	8.28	8.92	0.32	0.00	1.59	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	118.30	15.92	18.57	0.66	0.66	3.98	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	94.80	12.13	9.86	0.76	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	77.28	9.66	10.51	0.28	0.85	1.42	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	107.91	15.73	15.98	1.47	0.49	2.21	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	112.74	5.21	14.34	0.65	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	79.09	11.17	12.64	0.00	0.00	3.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	118.21	17.88	19.03	0.86	0.58	5.19	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	83.67	12.78	8.66	0.41	0.41	4.53	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	79.51	12.51	12.51	0.30	0.60	2.08	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	3.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	71.96	14.46	8.21	0.33	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	55.75	11.57	1.05	2.10	2.10	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	30.64	9.29	3.76	0.40	0.20	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	57.74	11.18	6.52	0.00	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	49.19	12.39	3.00	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	58.86	11.99	7.46	0.53	0.27	3.20	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	42.64	6.90	4.18	0.11	0.00	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	50.10	13.26	2.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	51.67	15.39	5.86	0.37	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	59.11	9.33	9.33	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.26	5.34	1.60	0.00	0.00	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	11.59	7.73	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	47.47	14.14	7.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	46.38	10.96	4.64	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	8.17	1.36	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	4.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	0.00	17.13	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	3.26	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	4.75	0.00	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	85.74	52.78	6.46	7.97	1.94	0.65	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	54.35	34.49	7.32	3.66	0.52	1.57	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	100.79	38.05	9.34	5.34	2.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	78.47	39.23	5.01	8.35	1.67	0.42	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	157.25	30.42	17.68	1.52	0.76	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	202.67	20.75	28.73	3.19	1.60	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	43.52	28.56	4.76	2.04	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	137.82	42.27	22.05	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	32.65	23.02	0.84	1.67	0.42	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	48.11	30.45	6.51	3.72	0.46	0.70	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	65.67	47.02	6.76	2.97	1.08	0.27	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	65.59	26.70	9.46	1.68	0.21	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	33.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	53.61	47.15	4.47	3.97	0.50	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	36.00	18.41	3.52	1.08	0.00	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	38.31	34.68	5.21	3.17	0.23	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	46.54	26.94	6.04	1.63	0.33	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	65.61	27.52	8.75	3.10	0.55	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	44.56	28.11	7.43	4.24	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	41.42	42.62	6.60	6.00	0.00	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	106.99	26.25	10.17	2.30	0.66	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	41.79	23.91	3.42	3.58	0.16	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	86.25	28.40	12.88	3.70	0.71	0.18	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	43.60	14.77	4.22	1.41	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	40.91	32.18	5.06	2.76	0.92	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	39.53	29.24	7.07	2.57	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	100.36	25.52	14.14	2.76	0.69	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	407.08	63.21	27.81	15.17	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	79.53	23.62	11.14	2.90	0.22	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	48.27	22.02	4.23	2.12	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	41.77	22.79	2.85	3.80	0.47	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	53.23	30.91	3.43	5.15	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	27.08	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	56.98	26.32	9.33	3.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	97.84	18.03	10.82	4.51	1.35	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	40.87	18.25	3.57	3.57	0.40	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	46.43	32.50	8.36	9.29	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	52.22	23.46	5.30	0.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	60.29	26.40	5.54	8.80	0.00	0.00	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	62.32	20.48	8.28	4.36	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	99.05	32.11	18.54	6.33	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	51.15	23.81	6.17	2.65	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	23.93	3.32	7.98	0.66	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	53.08	31.75	9.92	3.97	0.99	0.00	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	67.38	31.77	7.66	4.21	0.77	0.00	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	64.42	25.41	9.68	1.21	0.91	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	90.18	25.20	11.71	3.54	0.22	0.44	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	46.76	21.68	2.71	4.74	1.36	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	127.74	15.33	20.44	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	48.77	24.39	3.05	1.83	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	60.43	26.44	4.41	5.35	1.26	0.00	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.66	22.70	8.47	4.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	36.39	33.23	7.12	5.54	0.79	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	134.90	28.34	17.00	3.40	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	101.16	20.23	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	73.29	53.17	5.34	8.70	1.37	0.37	2.24
Myoblast, donor2	11322-117D8	114.50	55.43	11.70	5.18	0.77	0.77	1.15
Myoblast, donor3	11398-118D3	108.63	41.87	10.09	5.21	1.01	0.17	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	107.41	3.36	12.26	0.15	0.29	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	78.42	4.00	9.84	0.31	0.92	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	71.77	6.63	4.52	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	80.06	3.87	6.44	0.37	0.55	0.00	0.00
Neural stem cells, donor1	11275-116H6	174.57	34.12	11.61	2.90	1.09	0.00	0.00
Neural stem cells, donor2	11352-117H2	219.52	25.03	21.18	3.85	3.85	0.00	1.93
Neurons, donor1	11494-119E9	100.14	1.14	12.52	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	87.18	5.94	10.57	0.22	0.66	0.00	0.00
Neurons, donor3	11655-122E8	65.77	4.93	5.76	0.82	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	73.31	3.71	0.93	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	66.67	2.90	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	75.13	9.16	3.67	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	84.06	34.31	4.99	3.92	0.36	0.47	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	53.07	39.72	5.21	3.91	1.30	1.30	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	60.77	21.46	7.02	3.41	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	51.76	63.04	4.40	7.16	0.14	0.28	0.69
Olfactory epithelial cells, donor2	11934-125I8	78.31	67.02	7.67	6.66	1.30	0.87	1.59
Olfactory epithelial cells, donor3	11935-125I9	60.61	65.38	5.45	7.38	0.23	0.57	1.14
Olfactory epithelial cells, donor4	11936-126A1	80.74	82.69	7.89	9.64	1.07	1.17	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	155.27	29.49	6.62	1.81	2.41	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	70.40	38.50	5.74	8.93	1.06	0.43	2.34
Osteoblast - differentiated, donor2	11353-117H3	45.72	11.43	3.43	1.14	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	46.55	18.00	4.34	4.97	0.00	0.62	1.24
Osteoblast, donor1	11277-116H8	100.06	46.90	8.01	5.08	0.78	0.59	0.78
Osteoblast, donor2	11354-117H4	160.13	51.27	13.34	7.02	2.11	0.00	0.70
Osteoblast, donor3	11426-118G4	114.99	39.63	8.35	5.51	1.07	0.18	0.53
Pancreatic stromal cells, donor1	11249-116E7	76.99	32.01	4.13	5.90	1.01	0.08	1.43
Pericytes, donor1	11491-119E6	70.99	29.15	9.46	1.56	0.56	0.33	0.00
Pericytes, donor2	11571-120E5	85.79	28.07	15.85	2.04	1.81	0.00	0.00
Pericytes, donor3	11652-122E5	132.65	71.82	9.77	9.97	2.24	0.20	0.41
Perineurial Cells, donor1	11499-119F5	112.34	27.24	7.46	2.26	0.68	0.00	0.11
Perineurial Cells, donor2	11579-120F4	87.32	32.11	6.07	3.22	1.10	0.55	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	80.96	6.06	7.01	0.00	0.64	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	61.71	7.59	5.88	0.00	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	84.64	6.60	7.89	0.39	0.26	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	131.30	13.63	6.22	4.30	2.39	3.83	0.48
Placental Epithelial Cells, donor2	11355-117H5	103.13	32.16	7.76	7.76	2.22	12.20	0.00
Placental Epithelial Cells, donor3	11427-118G5	122.70	33.57	12.17	6.48	1.96	14.53	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.28	46.52	2.53	6.65	0.63	0.00	1.27
Preadipocyte - breast, donor1	11467-119B9	46.52	46.71	3.75	9.00	0.94	0.56	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	188.22	85.76	18.53	17.62	0.78	0.52	2.35
Preadipocyte - breast, donor2	11328-117E5	81.50	44.58	7.88	11.93	0.45	0.68	1.58
Preadipocyte - omental, donor1	11468-119C1	62.87	46.35	5.22	6.29	0.53	0.21	0.96
Preadipocyte - omental, donor2	11329-117E6	72.02	49.76	8.29	12.22	0.87	0.00	3.06
Preadipocyte - omental, donor3	11403-118D8	104.86	56.30	9.31	10.89	0.72	0.00	2.15
Preadipocyte - perirenal, donor1	11469-119C2	66.93	34.45	6.89	5.91	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	94.90	62.34	6.14	11.36	1.23	0.31	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	195.85	87.30	15.58	9.03	3.01	0.18	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	103.87	59.09	9.20	6.64	1.02	0.00	2.38
Preadipocyte - visceral, donor1	11280-116I2	145.40	81.32	10.99	9.50	2.51	0.47	1.30
Preadipocyte - visceral, donor2	11357-117H7	118.27	86.05	10.58	4.60	0.00	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	119.64	64.26	14.84	6.90	1.88	0.10	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	181.78	4.68	7.84	1.36	2.72	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	123.23	34.67	8.80	6.36	2.17	0.54	0.68
Prostate Epithelial Cells, donor3	11404-118D9	109.00	4.41	3.80	1.84	3.67	0.55	0.00
Prostate Stromal Cells, donor1	11254-116F3	108.09	39.07	4.56	7.97	2.51	0.46	1.82
Prostate Stromal Cells, donor2	11332-117E9	138.42	50.02	8.07	8.07	2.33	0.00	1.61
Prostate Stromal Cells, donor3	11405-118E1	62.15	39.31	4.48	8.55	0.21	0.42	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	158.77	18.61	12.41	1.09	3.28	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	102.72	8.66	5.13	0.55	1.46	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	222.17	18.77	17.25	0.51	2.03	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	178.54	22.76	12.09	1.42	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	91.15	12.07	4.76	0.53	1.16	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	91.92	53.11	16.34	8.85	2.04	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	123.44	71.83	13.88	9.03	1.08	0.13	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	210.02	44.18	19.98	6.22	1.78	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	130.43	55.90	14.64	5.99	1.33	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	175.19	36.09	18.71	1.98	1.32	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	121.64	36.99	13.17	2.51	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	107.08	24.13	8.60	0.28	1.11	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	252.32	27.92	14.76	0.81	4.29	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	122.71	16.87	10.12	0.84	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	197.48	24.68	15.23	0.96	3.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	112.79	4.15	5.19	0.00	0.78	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	149.23	12.79	15.63	1.14	1.71	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	186.27	10.29	15.44	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	87.57	4.01	3.51	0.50	2.51	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	118.00	49.98	5.88	6.55	1.20	0.27	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	80.41	6.25	16.97	0.00	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	68.25	6.05	21.46	0.55	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	75.41	10.44	20.88	0.58	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	113.38	8.58	25.35	0.13	0.78	1.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	140.22	11.12	23.04	0.40	1.79	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	113.66	7.36	13.94	0.11	0.89	1.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	117.10	9.06	23.82	0.12	0.50	0.99	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	140.09	9.32	20.63	0.70	1.17	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	140.53	8.32	26.35	0.23	0.69	1.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	112.81	7.67	32.72	0.27	0.14	1.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	122.68	7.87	21.18	0.30	1.36	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	103.93	7.35	13.98	0.18	1.25	1.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	107.16	6.31	32.28	0.57	0.57	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	123.09	7.94	19.42	0.32	1.29	1.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	132.54	6.20	24.34	0.22	1.55	1.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	100.75	7.07	42.06	0.38	0.57	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	134.71	10.25	21.80	0.75	1.40	1.68	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	131.53	5.26	17.85	0.38	0.94	2.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	131.38	8.89	41.40	0.27	1.19	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	140.37	9.73	24.63	0.19	0.58	1.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	133.48	7.26	16.61	0.00	1.72	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	125.27	8.44	37.16	0.53	1.07	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	128.66	9.81	19.34	0.28	1.40	1.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	141.16	10.94	23.75	0.00	1.54	2.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	123.07	6.20	33.73	0.18	0.73	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	143.11	9.57	23.67	0.37	1.35	1.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	128.54	6.72	23.91	0.40	1.07	1.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	108.03	5.90	37.74	0.24	0.24	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	138.10	10.91	19.84	0.99	0.99	1.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	133.99	8.18	19.88	0.23	1.64	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	125.24	8.50	31.93	0.21	0.21	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	137.15	7.74	19.69	0.66	0.44	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	146.01	7.10	23.81	0.84	1.25	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	134.85	11.98	39.43	0.27	0.54	1.35	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	154.97	11.75	26.40	0.17	2.04	2.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	154.04	10.80	21.01	0.39	1.35	1.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	116.06	13.58	43.16	0.52	0.69	1.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	147.46	13.44	24.42	0.82	2.33	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	124.60	10.67	22.49	0.49	0.82	1.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	108.91	10.74	40.73	0.17	0.68	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	141.00	12.58	24.41	0.74	1.04	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	137.81	14.39	27.19	0.27	2.40	1.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	115.59	6.50	28.76	0.14	1.11	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	108.34	8.10	18.81	0.00	0.71	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	171.51	10.68	31.04	0.40	0.81	1.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	86.45	9.13	29.01	0.38	0.75	1.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	121.23	6.29	20.61	0.35	1.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	130.25	8.76	21.76	0.60	0.60	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	92.89	8.32	32.43	0.24	0.86	1.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	140.75	8.73	20.23	0.44	2.18	1.46	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	104.65	8.52	20.08	0.61	2.43	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	84.39	5.43	32.85	0.00	0.60	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	132.09	10.40	19.00	0.90	1.81	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	112.63	11.38	19.17	0.30	0.60	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	96.35	9.80	20.31	0.59	0.35	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	109.71	10.03	14.94	0.85	0.64	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	97.36	12.02	16.23	1.80	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	146.51	30.47	19.18	2.07	2.26	0.00	0.00
Schwann Cells, donor2	11578-120F3	105.47	20.41	3.40	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	125.10	33.52	12.93	3.51	1.10	0.00	0.00
Sebocyte, donor1	11220-116B5	413.57	73.95	23.01	13.69	9.31	1.64	0.55
Sebocyte, donor2	11301-117B5	210.48	24.36	10.57	5.51	3.68	1.38	0.00
Sebocyte, donor3	11378-118B1	169.63	37.51	12.99	3.92	4.53	2.89	1.03
Sertoli Cells, donor1	11255-116F4	107.68	53.01	8.28	8.28	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	70.61	45.19	5.65	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	112.61	17.42	5.37	1.32	1.50	0.09	0.18
Skeletal Muscle Cells, donor2	11358-117H8	64.33	23.13	7.95	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	142.96	44.31	17.56	0.84	1.67	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	122.69	26.08	9.90	2.98	2.04	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	112.67	26.31	9.81	2.53	1.34	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	152.52	19.39	14.31	0.77	1.39	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	75.35	46.12	6.68	4.79	1.39	0.63	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	85.61	45.09	6.85	5.85	1.43	0.29	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	183.94	31.15	12.60	2.28	3.08	0.00	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	106.83	44.65	10.87	4.47	1.60	0.08	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	82.51	11.58	9.41	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	70.04	28.62	9.91	2.48	0.83	0.14	0.14
Skin - palm, donor1	10286-104F7	139.68	8.06	5.37	2.69	5.37	10.74	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	128.30	27.68	11.39	5.77	1.30	0.58	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	166.85	58.07	12.27	12.27	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	109.96	20.51	7.27	2.60	1.43	0.65	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	73.40	26.13	2.50	2.78	2.22	0.00	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	125.18	31.37	6.33	7.60	5.06	0.28	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	219.48	34.04	16.49	5.71	4.02	1.27	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	145.25	20.54	4.57	3.75	7.35	0.37	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	28.70	42.28	4.01	9.87	1.23	0.00	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	229.00	91.38	36.46	19.34	1.11	0.67	2.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	85.23	68.19	8.82	7.64	0.59	0.00	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	176.35	71.82	11.71	12.38	0.88	1.33	1.55
Smooth Muscle Cells - Aortic, donor2	11360-117I1	125.22	76.79	12.60	12.99	3.15	0.00	1.97
Smooth Muscle Cells - Aortic, donor3	11432-118H1	109.70	54.85	7.73	6.18	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	47.04	37.03	3.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	90.23	77.45	7.45	16.77	0.80	0.27	3.46
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	90.21	40.56	6.65	10.42	1.11	0.66	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	44.30	25.22	5.25	6.66	0.77	0.38	1.15
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	65.44	20.51	6.19	1.63	0.98	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	83.28	27.17	8.56	4.73	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	80.01	36.59	6.98	4.98	0.85	0.14	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	162.67	69.14	11.88	10.57	3.42	0.00	1.79
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	95.59	27.70	4.87	3.04	1.83	0.91	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	92.19	54.30	7.32	5.81	0.51	0.25	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	495.78	12.24	36.72	18.36	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	65.33	41.96	10.49	9.06	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	64.45	24.19	3.69	3.54	1.18	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	82.44	33.58	5.60	2.58	1.08	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	102.12	30.75	9.03	3.57	1.57	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	141.84	86.47	11.45	12.99	1.08	0.31	3.25
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	94.85	85.15	8.62	19.40	1.08	0.00	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	95.93	44.83	9.56	5.98	1.49	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	204.50	61.45	13.31	5.12	2.39	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	52.54	32.90	4.63	2.75	0.55	0.63	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	120.47	104.26	8.05	13.39	1.81	0.40	2.72
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	110.36	72.59	9.56	14.79	1.37	0.00	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	76.08	54.34	8.45	11.47	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	257.24	33.12	15.63	3.71	5.30	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	81.63	29.83	7.59	5.06	1.20	0.67	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	92.29	51.47	7.51	6.89	1.50	0.63	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	32.98	25.11	3.80	4.57	0.00	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	109.61	90.01	9.80	19.75	1.66	0.30	2.86
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	69.77	40.51	8.25	6.00	2.25	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	786.96	220.97	102.08	12.92	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	105.57	68.37	12.09	9.77	0.47	0.00	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	104.01	87.34	9.09	14.14	0.50	0.50	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	91.51	54.22	11.60	7.83	1.25	0.00	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	101.48	59.88	9.44	11.50	2.95	1.47	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	207.52	49.73	8.33	8.08	4.00	0.92	1.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	73.81	61.20	4.67	10.28	0.00	0.47	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	99.88	54.98	8.92	10.22	0.86	0.58	1.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	117.02	49.72	7.90	12.24	0.76	0.00	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	93.08	37.98	8.46	5.08	1.32	0.38	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	130.38	24.04	9.36	1.82	1.54	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	83.87	31.42	4.52	3.94	1.09	0.25	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	68.57	10.95	5.24	1.43	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	120.62	53.09	11.74	9.05	0.49	0.73	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	93.68	52.81	11.05	12.37	1.10	0.44	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	82.21	24.58	5.27	2.63	1.17	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.48	33.62	4.66	3.50	0.39	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	69.29	43.11	6.08	4.23	1.06	0.00	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.24	43.52	5.95	4.09	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	62.88	63.96	6.83	12.58	0.00	1.44	3.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	71.83	37.47	5.96	13.06	1.14	0.28	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	88.23	31.12	8.67	4.73	0.79	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	43.43	36.57	3.05	4.83	0.51	0.25	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	39.13	38.33	3.99	4.79	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	39.71	29.26	3.34	7.11	0.00	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	36.21	25.67	2.75	3.21	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	82.48	65.14	6.23	12.62	0.67	0.84	3.87
Synoviocyte, donor2	11368-117I9	57.66	31.35	4.19	11.06	0.34	0.34	3.52
Synoviocyte, donor3	11440-118H9	42.89	25.69	7.60	10.28	0.00	0.67	2.23
Trabecular Meshwork Cells, donor1	11532-120A2	323.74	50.38	24.66	2.86	3.22	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	118.92	45.59	1.98	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	151.43	37.51	14.36	1.62	2.08	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	99.86	13.26	4.66	1.08	3.73	0.36	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	87.75	13.14	5.03	0.39	1.16	0.39	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	75.02	14.89	7.44	2.29	1.15	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	117.98	45.77	10.09	6.27	0.49	0.12	0.49
Urethra, donor2	10319-105A4	88.12	5.40	8.99	7.19	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	163.38	30.55	14.88	4.25	2.39	0.27	0.27
Urothelial Cells, donor2	11600-120H7	118.97	19.63	11.62	3.20	2.00	1.20	1.60
Urothelial Cells, donor3	11681-122H7	114.60	23.84	6.42	2.75	2.29	1.83	0.46
Urothelial cells, donor0	11216-116B1	110.33	37.22	5.13	3.57	2.23	1.34	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	59.62	3.56	7.12	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	64.33	7.15	4.29	0.00	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	54.76	2.05	4.79	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	53.72	2.41	5.17	0.34	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.67	2.32	2.32	0.58	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	53.10	2.08	8.33	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	50.48	1.84	8.26	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	50.21	1.83	4.56	0.91	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	149.88	6.04	17.64	0.49	1.97	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	169.85	6.16	6.16	0.88	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	202.23	17.32	14.52	1.96	4.47	5.03	0.00
achilles tendon, donor2	10292-104G4	115.73	8.27	14.47	2.07	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	222.32	7.90	19.63	0.51	4.59	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	173.20	5.57	10.45	0.00	0.46	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	160.37	3.21	13.06	0.12	1.31	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	155.10	5.17	10.07	0.00	2.99	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	168.65	12.65	17.43	1.69	1.97	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	51.60	2.75	3.60	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	144.00	26.13	11.43	1.91	1.63	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	114.13	3.53	9.69	0.00	1.76	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	165.79	20.42	21.64	1.23	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	135.90	9.32	11.26	0.78	0.78	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	188.05	4.97	21.71	0.18	3.68	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	124.82	0.00	19.50	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	178.47	28.35	19.75	2.56	2.56	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	219.81	3.62	32.10	0.00	1.81	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	201.06	14.32	22.21	0.00	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	158.48	17.66	10.22	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	95.00	2.06	13.16	0.00	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	260.91	13.81	20.87	1.23	3.07	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	239.81	15.79	16.64	1.71	2.99	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	218.98	14.86	21.53	2.12	2.73	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	263.57	18.78	22.63	1.44	3.61	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	197.57	2.90	18.49	0.45	5.12	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	244.49	3.34	28.02	0.00	1.33	2.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	334.48	31.59	26.01	5.57	7.43	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	94.17	5.65	5.65	1.13	1.13	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	193.21	3.93	34.89	0.44	2.62	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	256.80	3.75	16.87	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	106.68	8.48	17.90	1.65	1.41	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	99.59	21.25	5.12	3.10	0.78	0.78	1.40
adipose, donor1	10184-103D4	91.48	1.76	4.10	0.59	1.17	0.00	0.00
adipose, donor2	10185-103D5	75.02	3.24	2.84	0.00	1.62	0.00	0.00
adipose, donor3	10186-103D6	115.18	3.00	6.26	0.54	1.09	0.00	0.00
adipose, donor4	10187-103D7	396.97	0.00	33.80	0.00	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	212.11	5.84	25.41	0.32	3.16	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	87.30	21.83	10.91	0.00	0.00	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	116.60	2.00	10.27	0.53	1.73	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	117.91	16.44	14.65	0.71	2.50	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	78.83	15.77	10.67	9.27	1.16	26.43	0.00
amniotic membrane cells, donor2	12236-129G4	131.52	10.14	13.19	1.69	0.68	15.21	0.00
amniotic membrane cells, donor3	12237-129G5	95.45	9.43	16.20	3.24	1.77	66.29	0.00
amygdala - adult, donor10196	10167-103B5	99.61	16.60	22.53	1.19	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	98.34	17.03	11.15	0.61	0.81	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	54.55	11.94	6.13	0.65	0.65	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	92.82	19.23	2.80	0.64	2.67	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	295.86	4.19	22.72	0.00	4.41	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	113.91	2.67	15.37	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	71.39	18.83	5.88	5.49	0.59	0.20	2.55
appendix, adult	10189-103D9	127.30	15.52	10.48	3.88	0.78	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	126.91	16.85	13.41	1.72	0.34	0.00	0.00
artery, adult	10190-103E1	164.40	14.95	20.38	4.08	1.36	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	140.09	6.66	7.68	0.14	0.43	0.00	0.14
b cell line:RPMI1788	10427-106D4	225.58	12.04	16.06	0.59	5.06	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	64.09	42.17	6.10	10.82	1.11	0.00	3.61
bile duct carcinoma cell line:HuCCT1	10432-106D9	179.81	8.43	10.12	0.40	5.26	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	131.39	1.84	4.69	0.17	2.01	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	66.55	2.80	10.63	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	110.05	13.36	5.76	8.15	0.43	0.98	4.24
blood, adult, pool1	10053-101G8	33.22	2.21	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	118.18	41.96	10.28	14.56	0.00	2.57	4.28
bone marrow, adult	10192-103E3	97.17	23.62	8.77	1.35	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	60.48	18.45	13.33	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	77.28	14.48	8.46	0.78	1.00	0.11	0.00
brain, fetal, pool1	10085-102B4	53.43	2.67	10.69	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	158.91	4.29	16.52	1.98	2.64	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	327.41	14.10	11.61	1.12	6.12	7.74	0.12
breast, adult, donor1	10080-102A8	84.60	25.89	7.58	5.68	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	217.74	23.63	14.99	3.43	7.24	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	142.86	7.42	12.06	0.62	3.09	1.24	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	38.45	9.90	3.22	0.23	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	161.23	10.89	14.77	3.15	3.39	4.84	0.48
carcinoid cell line:NCI-H1770	10703-109H1	78.52	2.82	8.93	0.00	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	117.58	9.84	7.88	2.19	1.31	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	106.16	10.14	8.56	0.00	2.85	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	127.50	17.83	10.65	3.46	1.86	0.00	0.53
caudate nucleus - adult, donor10196	10177-103C6	79.44	18.42	9.21	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	93.54	14.89	7.86	0.33	0.67	0.67	0.17
caudate nucleus, adult, donor10258	10379-105H1	64.19	9.17	6.11	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	54.20	6.59	4.39	0.73	0.37	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	81.57	5.83	34.96	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	120.21	6.19	17.29	0.43	0.43	0.21	0.00
cerebellum, adult, pool1	10083-102B2	44.84	4.14	6.21	0.34	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	58.12	6.64	8.30	0.00	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	56.48	6.30	8.32	0.25	0.50	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	75.28	4.39	6.58	0.73	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	135.73	5.18	6.18	0.29	1.87	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	159.09	16.74	7.13	13.92	3.98	31.49	1.66
cervix, adult, pool1	10013-101C4	113.18	21.63	7.45	7.45	0.52	5.67	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	82.49	17.42	5.57	2.37	0.56	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	148.91	19.59	5.23	3.92	3.92	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	175.60	4.85	10.94	1.62	4.35	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	141.69	3.33	6.04	0.25	2.34	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	439.02	3.08	35.34	0.47	11.38	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	61.83	4.56	3.99	0.85	0.57	9.12	0.00
chorionic membrane cells, donor2	12239-129G7	120.11	27.64	10.34	2.78	1.59	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	79.68	2.20	8.79	2.20	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	112.09	4.04	5.05	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	132.16	7.30	11.53	0.38	1.15	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	130.51	15.84	7.39	6.76	0.84	0.63	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	208.01	4.11	23.88	0.51	3.34	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	226.16	7.74	25.88	0.24	1.69	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	225.60	5.50	22.60	0.00	2.44	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	157.53	3.53	9.13	0.29	1.77	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	194.17	21.63	8.34	2.87	0.52	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	90.75	4.34	8.69	0.23	0.46	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	100.11	3.30	8.15	0.52	1.91	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	138.93	8.05	8.42	1.28	2.20	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	305.97	16.72	47.89	0.38	3.80	0.00	0.00
colon, adult, donor1	10082-102B1	60.69	19.04	3.57	7.14	1.19	0.00	2.38
colon, adult, pool1	10014-101C5	111.16	21.86	10.22	4.23	0.82	0.47	1.18
colon, fetal, donor1	10070-101I7	31.52	9.27	4.33	1.85	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	311.68	9.17	9.17	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	124.51	10.20	14.45	2.97	1.27	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	169.19	17.81	15.85	1.21	2.72	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	174.57	21.01	18.61	0.85	2.12	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	106.03	22.00	13.60	1.33	2.10	0.88	0.11
cruciate ligament, donor2	10295-104G7	111.84	4.05	4.05	2.43	1.62	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	89.89	16.05	10.43	0.00	1.61	0.00	0.00
diencephalon, adult	10193-103E4	62.88	9.60	7.68	0.00	0.48	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	159.58	2.53	14.01	0.00	2.07	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	161.04	2.82	10.00	0.51	8.21	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	136.73	16.61	7.70	1.93	4.81	0.00	0.48
ductus deferens, adult	10196-103E7	137.54	27.41	11.46	4.98	1.00	0.50	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	44.65	12.96	0.00	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	125.06	22.07	19.13	0.74	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	115.04	17.18	5.29	3.63	1.73	0.58	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	208.53	4.89	8.66	0.67	7.77	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	230.85	7.31	12.18	0.86	4.30	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	229.38	3.08	8.63	0.00	3.70	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	140.76	3.03	6.05	0.61	2.42	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	208.10	4.63	7.41	0.62	8.34	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	267.95	2.63	17.08	1.31	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	208.16	32.85	11.06	2.35	8.72	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	109.28	9.61	5.44	0.18	1.45	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	127.52	4.82	6.91	0.48	0.96	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	195.86	28.79	12.78	11.00	3.67	6.34	2.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	292.78	8.58	15.07	0.99	6.05	0.00	0.00
epididymis, adult	10197-103E8	118.26	30.35	14.02	4.19	2.30	0.63	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	92.61	20.76	3.73	1.42	3.02	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	82.19	99.49	6.69	13.76	1.97	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	285.16	9.70	27.39	1.05	3.01	0.39	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	264.95	8.66	27.26	0.59	3.35	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	277.72	8.96	27.56	1.23	3.47	0.22	0.00
esophagus, adult, pool1	10015-101C6	138.03	24.10	8.71	18.26	1.59	16.99	2.87
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	149.53	14.03	14.65	0.63	2.38	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	77.27	4.83	9.66	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	86.27	10.52	8.42	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	80.36	2.98	10.42	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	81.40	4.59	3.44	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	75.78	2.91	7.29	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	57.46	7.88	6.36	1.27	0.51	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	182.98	10.64	12.05	0.77	3.46	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	179.25	9.50	8.07	0.95	4.27	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	81.16	13.04	12.10	0.56	0.47	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	188.26	9.01	12.31	2.40	1.50	10.81	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	130.21	26.79	7.22	1.19	2.19	0.55	0.00
gall bladder, adult	10198-103E9	119.27	23.90	14.00	5.31	0.97	0.72	2.17
gamma delta positive T cells, donor1	11937-126A2	68.72	6.44	7.52	0.00	1.07	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	46.69	4.48	4.86	0.37	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	112.16	9.72	7.82	1.06	2.96	1.27	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	203.86	9.48	12.19	1.93	2.90	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	145.10	14.59	8.69	0.82	2.13	0.00	0.33
gastric cancer cell line:GSS	10560-108A2	103.42	3.66	11.90	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	171.57	21.93	16.22	2.06	1.83	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	102.58	0.69	1.26	0.00	4.25	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	148.50	13.72	3.92	1.26	7.14	2.10	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	185.07	5.24	17.96	2.24	3.99	7.98	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	123.71	17.21	11.19	0.21	2.43	6.12	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	115.72	19.24	11.94	0.84	3.09	4.77	0.00
glioblastoma cell line:T98G	10485-107A8	115.67	43.60	7.06	3.31	1.88	1.43	0.44
glioma cell line:GI-1	10413-106B8	139.70	51.84	12.30	2.93	1.76	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	65.60	13.85	6.56	3.64	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	130.59	18.31	13.18	0.49	1.71	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	72.57	5.48	8.22	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	67.68	7.46	4.80	1.60	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	320.58	34.26	14.68	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	43.71	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	100.48	45.12	11.20	4.80	0.32	1.60	0.32
hIPS +CCl2, biol_rep1	14383-156B9	164.82	4.59	12.86	1.84	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	171.47	5.94	16.00	0.00	0.91	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	146.21	3.86	13.53	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	135.11	4.31	8.62	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	134.43	4.80	14.40	0.69	3.43	0.00	0.00
hIPS, biol_rep3	14382-156B8	88.28	9.93	12.14	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	134.19	1.15	9.19	0.00	5.46	0.29	0.00
heart - mitral valve, adult	10205-103F7	102.25	19.13	11.66	4.48	1.20	0.60	1.49
heart - pulmonic valve, adult	10206-103F8	101.71	18.56	11.77	5.23	0.78	3.66	4.18
heart - tricuspid valve, adult	10207-103F9	213.99	7.49	5.83	2.50	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	148.96	23.26	12.45	4.08	2.24	7.75	0.82
heart, adult, diseased, donor1	10051-101G6	113.27	11.07	12.35	4.26	1.28	1.70	1.28
heart, adult, pool1	10016-101C7	142.59	11.50	6.44	4.37	1.84	2.76	1.38
heart, fetal, pool1	10046-101G1	141.70	20.54	12.32	4.11	1.13	0.31	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	70.96	65.72	6.17	14.50	0.62	0.00	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	246.16	10.70	24.97	5.95	7.14	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	243.09	58.12	12.93	5.86	1.88	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	254.52	58.75	16.99	4.01	1.70	0.00	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	264.76	66.19	17.48	3.54	2.22	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	116.33	4.78	3.67	0.44	1.67	0.67	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	251.75	2.81	20.00	0.50	4.02	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	83.28	17.98	20.82	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	104.09	16.74	10.82	0.41	1.22	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	50.29	6.97	22.91	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	50.05	9.52	6.34	1.06	1.76	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	140.99	3.66	6.71	0.00	1.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	133.91	1.37	4.52	0.39	1.57	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	157.67	1.52	6.60	0.25	2.54	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	104.31	2.26	6.20	0.56	1.13	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	97.35	3.36	5.94	0.00	2.07	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	93.38	1.14	7.59	0.00	1.52	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	94.30	2.92	11.97	0.00	1.75	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	107.28	4.95	5.39	0.43	1.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	102.18	5.00	7.51	1.25	2.92	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	72.46	3.55	5.21	0.47	0.24	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	106.07	5.79	8.68	0.80	1.61	0.00	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	83.49	4.04	6.73	0.00	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	163.37	3.60	7.51	0.00	2.50	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	158.20	3.44	9.33	0.00	2.95	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	61.97	2.62	6.11	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	120.27	3.82	7.64	0.57	1.53	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	113.82	2.62	6.98	0.00	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	85.46	5.00	4.50	0.50	1.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	67.82	3.77	2.83	0.19	1.51	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	56.38	2.73	2.73	0.45	0.91	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	59.83	4.70	3.13	0.31	1.25	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	64.18	5.88	5.06	0.49	0.33	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	72.58	3.77	6.68	0.29	0.58	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.33	5.68	6.58	0.30	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	144.10	1.66	5.17	0.18	3.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	161.76	3.71	8.56	0.00	2.85	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	137.19	3.67	8.57	0.82	2.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	122.17	3.17	8.10	0.70	2.82	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	108.01	4.12	5.38	0.00	1.58	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	115.00	4.84	6.05	0.30	2.42	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	96.18	3.10	6.21	0.52	1.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	75.71	3.32	2.66	0.66	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	78.76	3.33	6.67	0.26	2.05	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	85.90	4.60	9.71	1.53	0.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	77.99	4.54	9.09	0.76	0.76	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	84.35	5.04	8.07	2.02	1.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	156.01	2.42	7.00	0.00	1.45	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	133.70	2.67	2.23	0.00	2.67	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	159.03	2.44	10.24	0.49	3.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	117.05	4.28	7.64	0.31	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	84.58	0.00	6.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	87.37	1.99	3.97	0.33	1.65	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	100.70	3.28	10.95	0.00	3.28	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	77.44	2.17	6.15	0.00	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	76.51	2.14	5.34	0.36	1.78	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	77.57	3.58	4.77	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	106.17	3.79	6.36	0.27	0.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	75.43	3.23	5.66	0.00	0.81	0.00	0.00
immature langerhans cells, donor1	11904-125F5	60.29	4.84	7.75	0.00	0.48	1.45	0.00
immature langerhans cells, donor2	11905-125F6	81.59	10.30	6.34	19.01	0.79	14.26	1.58
insula, adult, pool1	10039-101F3	101.35	16.84	12.49	1.04	1.32	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	129.73	12.68	16.91	11.38	2.93	1.30	0.65
kidney, adult, pool1	10017-101C8	151.09	54.57	10.91	5.91	1.90	0.40	0.40
kidney, fetal, pool1	10045-101F9	126.26	18.25	10.75	1.63	1.77	0.07	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	181.50	16.05	10.65	1.85	2.98	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	47.42	5.11	5.81	0.28	1.24	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	194.69	5.87	2.75	0.92	11.01	0.00	0.00
left atrium, adult, donor1	10079-102A7	56.12	11.44	8.72	1.63	0.54	0.00	1.63
left ventricle, adult, donor1	10078-102A6	53.09	10.11	8.09	3.03	1.01	1.01	1.52
leiomyoblastoma cell line:G-402	10721-110A1	153.22	35.30	10.40	5.47	2.74	0.00	1.92
leiomyoma cell line:10964C	10569-108B2	60.71	47.78	4.31	8.62	1.44	1.44	3.23
leiomyoma cell line:15242A	10570-108B3	48.37	34.78	4.35	5.43	1.09	0.54	1.63
leiomyoma cell line:15425	10571-108B4	68.47	53.91	5.58	13.35	0.97	2.43	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	19.05	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	134.88	4.18	17.77	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	151.82	19.83	11.92	1.18	1.42	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	47.33	11.40	7.81	1.56	0.47	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	108.92	33.75	12.67	2.80	0.97	0.49	0.37
liver, adult, pool1	10018-101C9	294.14	131.92	11.18	7.13	2.76	1.13	0.00
liver, fetal, pool1	10086-102B5	74.32	33.87	4.70	1.88	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	77.87	18.37	7.29	1.60	1.46	0.29	0.44
locus coeruleus, adult, donor10252	10165-103B3	105.19	12.55	8.67	0.55	0.55	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	50.50	14.67	6.21	0.28	0.85	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	83.70	9.25	10.09	2.10	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	57.02	30.03	3.04	1.52	1.11	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	246.81	22.06	11.03	4.14	3.45	13.79	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	171.23	30.98	20.04	5.14	2.50	3.82	0.40
lung, adult, pool1	10019-101D1	113.52	28.59	5.32	7.09	1.77	6.02	0.24
lung, fetal, donor1	10068-101I5	152.12	22.55	17.41	6.56	2.00	10.85	0.29
lung, right lower lobe, adult, donor1	10075-102A3	101.27	16.95	5.50	6.87	1.37	2.29	0.92
lymph node, adult, donor1	10077-102A5	66.74	14.67	6.63	1.42	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	126.47	5.70	11.62	0.44	1.97	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	127.23	1.66	11.17	0.15	1.51	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	362.73	3.40	17.84	1.70	6.80	2.55	1.70
mature adipocyte, donor1	12231-129F8	110.11	43.07	5.77	9.32	2.22	1.78	4.44
mature adipocyte, donor2	12232-129F9	94.01	42.75	6.02	6.64	0.83	2.91	2.28
mature adipocyte, donor3	12233-129G1	85.11	48.36	7.82	5.93	1.19	1.90	3.56
mature adipocyte, donor4	12234-129G2	73.44	46.59	6.58	5.26	1.05	2.11	4.47
maxillary sinus tumor cell line:HSQ-89	10414-106B9	253.98	24.54	12.63	0.48	6.43	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	68.81	11.28	14.66	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	96.00	12.14	10.11	0.18	0.92	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	40.03	6.35	11.75	0.64	0.64	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	45.21	6.40	5.54	0.43	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	60.58	17.55	10.63	1.52	2.03	0.34	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	109.93	18.04	14.22	0.64	1.49	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	36.60	3.85	9.63	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	46.66	5.38	13.28	1.08	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	73.98	17.52	11.03	1.95	0.65	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	112.39	14.09	12.23	0.77	0.62	0.15	0.15
medulla oblongata, adult, pool1	10038-101F2	102.44	21.22	9.71	1.47	1.71	0.33	0.24
medulla oblongata, newborn, donor10223	10361-105F1	60.76	7.64	11.11	1.04	1.39	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	232.26	5.76	8.86	0.22	3.76	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	166.29	13.45	12.47	0.61	3.42	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	134.55	2.87	8.19	0.14	1.72	0.00	0.00
melanoma cell line:G-361	10465-106H6	178.89	3.26	5.97	0.00	4.61	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	84.48	14.65	7.78	1.09	1.09	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	180.64	16.74	18.50	0.88	2.64	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	173.16	5.44	20.74	0.26	2.07	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	94.36	56.77	8.29	7.21	0.00	0.61	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	54.90	41.81	3.82	5.82	0.73	0.00	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	56.73	37.27	7.04	7.45	0.41	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	56.33	38.21	9.69	2.25	0.28	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.65	29.66	7.32	2.12	0.39	0.96	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	72.88	36.09	8.33	6.25	1.39	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	59.04	35.36	3.60	3.26	0.86	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	79.25	38.65	7.82	4.37	0.35	1.15	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	83.96	40.32	9.68	3.58	0.53	0.27	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	87.10	41.59	8.10	4.73	0.68	0.14	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	101.72	54.63	8.11	4.27	0.85	0.57	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	84.97	43.80	4.61	3.62	0.66	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	108.62	48.85	13.28	5.12	0.55	0.28	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	94.60	59.69	12.92	5.24	1.05	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	61.05	29.60	4.90	3.47	1.22	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	86.27	48.89	6.47	7.91	0.72	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	62.17	29.59	7.14	3.41	0.21	0.21	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	86.18	56.77	8.66	8.66	0.91	0.68	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	104.89	33.56	9.23	5.03	0.42	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	77.11	33.03	7.77	4.03	0.90	0.15	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	72.83	50.59	8.75	3.33	0.96	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	62.22	55.59	4.79	4.05	1.10	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	102.16	57.23	9.73	8.01	0.86	0.57	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	90.94	17.26	6.74	1.68	2.53	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	60.28	35.62	5.48	10.05	0.00	0.00	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	67.78	43.74	5.37	16.63	0.51	0.77	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	66.75	56.54	4.97	15.97	0.52	0.79	2.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	66.24	47.75	8.01	16.64	1.85	0.62	3.08
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	60.25	37.66	4.24	17.42	0.94	0.24	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	73.11	46.71	3.05	12.86	0.68	0.34	3.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	58.55	41.26	6.29	15.33	0.79	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.34	41.24	4.63	10.19	0.93	1.39	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.30	55.38	6.06	12.98	0.87	0.58	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	69.16	43.50	6.02	12.72	1.12	0.67	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	67.06	49.75	7.45	12.98	1.44	0.48	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	98.27	76.27	9.53	19.07	1.47	2.20	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	56.73	40.28	3.36	9.40	0.34	0.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	58.54	47.08	4.50	10.23	0.82	0.00	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	58.85	47.25	5.58	9.45	0.86	0.86	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	43.75	13.67	2.73	2.73	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	30.99	0.00	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	50.99	39.95	5.52	7.79	0.97	1.30	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	62.56	21.82	1.45	7.27	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	41.05	35.18	3.73	8.00	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	44.98	29.44	3.27	9.00	1.64	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	51.70	25.66	7.77	11.66	0.00	0.00	3.11
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	25.18	4.20	14.69	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	37.75	42.72	4.97	7.95	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	14.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	38.54	28.46	6.52	7.12	0.59	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	40.21	47.52	6.09	15.84	0.00	0.00	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	54.10	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	46.87	31.04	6.33	7.60	0.00	0.00	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.14	29.66	1.38	8.62	0.00	0.34	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	23.64	0.00	10.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	23.95	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	44.77	0.00	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	27.71	28.12	2.04	6.93	0.00	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	36.54	4.77	7.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	29.48	25.94	4.13	4.72	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	28.05	23.69	3.74	4.68	0.31	0.31	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	38.76	37.43	4.01	8.02	0.00	0.00	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	37.85	30.75	7.10	4.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	17.98	10.27	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	55.07	27.54	3.44	4.82	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	68.28	27.71	7.92	2.47	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	57.20	29.16	5.61	4.49	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	53.43	23.53	6.36	3.18	1.91	1.91	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	57.22	23.78	5.64	1.61	0.81	2.42	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	56.70	13.08	4.36	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	60.82	24.07	6.34	6.34	1.27	3.80	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	59.47	24.88	5.46	2.43	1.21	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	54.23	4.52	9.04	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	29.65	22.24	3.29	2.47	1.65	3.29	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.79	20.24	1.79	4.17	0.40	0.60	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	42.83	25.31	3.89	5.19	0.97	0.97	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	42.78	36.67	3.06	8.15	0.00	4.07	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	89.75	29.40	8.51	13.15	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	160.41	10.16	4.25	1.65	6.38	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	183.72	85.95	16.45	12.51	3.94	34.29	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	119.66	81.20	25.64	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	88.47	42.33	6.58	4.21	0.92	7.81	0.10
mesothelioma cell line:Mero-25	10850-111F4	211.29	7.72	10.21	0.68	9.53	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	190.20	38.63	16.62	6.11	1.96	1.22	0.49
mesothelioma cell line:Mero-48a	10852-111F6	145.26	24.58	23.03	1.55	0.89	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	119.05	18.92	10.25	4.20	1.84	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	105.71	43.07	20.09	4.26	1.19	2.04	0.00
mesothelioma cell line:Mero-84	10855-111F9	106.42	13.65	15.42	3.29	1.77	9.35	0.00
mesothelioma cell line:Mero-95	10856-111G1	125.05	38.72	11.80	2.90	1.24	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	138.32	32.80	12.75	2.15	2.48	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	118.55	58.82	12.85	10.50	0.54	3.44	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	113.26	31.26	12.47	5.47	1.37	5.64	0.51
mesothelioma cell line:NCI-H28	10845-111E8	94.15	2.04	18.32	0.51	1.27	0.00	0.00
mesothelioma cell line:No36	10857-111G2	124.61	4.89	8.81	0.65	0.65	1.96	0.00
mesothelioma cell line:ONE58	10858-111G3	164.74	21.41	16.53	3.79	1.63	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	100.76	24.76	13.63	4.99	0.77	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	110.15	19.54	12.21	6.96	0.61	1.59	0.73
migratory langerhans cells, donor3	11903-125F4	73.23	7.54	9.51	0.72	0.54	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	96.31	2.29	3.26	0.00	1.63	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	57.43	17.17	2.76	0.21	1.27	0.85	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	171.16	20.04	8.75	1.84	4.84	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	82.97	2.09	7.99	0.19	1.33	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	208.08	1.29	14.97	0.00	2.40	0.00	0.00
myeloma cell line:PCM6	10474-106I6	102.98	29.65	7.91	4.55	1.78	0.00	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	93.85	6.59	15.22	1.01	0.00	2.54	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	87.48	10.98	15.10	0.98	0.20	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	72.09	4.79	1.34	1.23	4.57	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	59.49	3.53	0.59	0.88	3.09	0.29	0.07
nasal epithelial cells, donor2	12227-129F4	225.76	20.42	13.25	3.86	3.86	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	143.10	13.80	14.72	0.23	1.38	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	231.24	13.28	18.90	0.19	2.81	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	125.06	1.69	12.23	0.00	1.05	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	168.83	5.03	19.57	0.19	1.30	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	77.34	0.24	12.81	0.00	0.00	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	108.49	4.28	9.19	0.32	0.79	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	139.47	10.67	12.68	0.40	1.01	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	299.45	2.54	26.07	0.00	3.18	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	78.52	60.42	5.32	10.11	0.53	0.00	0.53
neutrophil PMN, donor1	12133-128D9	163.62	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	122.10	6.43	5.41	0.00	1.69	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	49.63	6.40	4.80	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	55.79	29.50	4.49	6.09	0.96	0.00	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	66.22	31.79	4.99	5.52	1.05	0.26	1.05
nucleus accumbens, adult, pool1	10037-101F1	90.18	15.84	11.53	1.12	1.22	0.47	0.00
occipital cortex - adult, donor10196	10172-103C1	39.15	10.30	18.54	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	112.18	15.83	12.61	1.07	1.07	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	59.69	8.73	10.92	1.82	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	59.04	10.50	7.87	1.05	1.84	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	47.20	3.86	13.73	0.43	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	76.24	13.72	11.67	0.63	1.34	0.08	0.24
olfactory region, adult	10195-103E6	63.62	8.98	11.08	0.76	1.15	0.00	0.38
optic nerve, donor1	10277-104E7	74.04	2.00	6.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	218.93	24.49	17.54	1.48	2.62	0.34	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	173.66	14.70	5.77	1.79	5.50	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	100.58	25.57	5.42	4.06	1.19	8.80	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	201.33	6.47	13.40	0.81	3.58	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	86.43	35.86	7.94	5.59	0.59	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	189.67	18.69	8.41	2.80	4.67	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	130.42	36.47	10.82	4.88	1.48	2.76	1.91
ovary, adult, pool1	10020-101D2	130.07	12.58	6.73	2.36	1.14	0.35	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	70.76	12.28	6.23	1.65	0.73	0.00	0.37
pancreas, adult, donor1	10049-101G4	162.73	42.33	15.05	3.76	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	185.05	2.24	15.93	0.28	4.47	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	133.90	11.41	7.33	2.04	1.02	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	138.43	14.41	8.78	1.66	2.48	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	75.96	13.00	11.07	0.92	0.55	0.18	0.18
parietal cortex, adult, donor10258	10373-105G4	126.25	3.67	22.02	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	52.67	7.52	8.46	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	83.80	7.41	8.84	0.29	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	87.33	13.22	12.25	0.53	1.15	0.18	0.18
parietal lobe, fetal, donor1	10072-101I9	44.61	3.88	16.49	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	58.70	9.72	11.59	0.75	1.12	0.00	0.37
parotid gland, adult	10199-103F1	178.22	17.88	10.48	1.85	0.00	0.00	0.00
penis, adult	10200-103F2	99.90	17.72	12.89	3.76	0.00	3.76	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	32.54	0.74	1.49	0.00	0.56	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	136.22	21.42	7.87	1.89	2.33	1.17	0.44
pineal gland - adult, donor10196	10179-103C8	70.95	5.16	10.32	0.65	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	94.16	2.96	14.21	0.00	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	53.30	3.76	7.52	0.63	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	153.79	22.26	15.18	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	190.23	20.85	17.20	1.56	1.04	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	100.45	28.09	11.92	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	139.75	13.98	13.33	3.44	1.94	1.40	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	123.55	1.99	9.80	0.13	2.65	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	80.00	30.19	8.56	4.98	1.40	2.49	0.31
pons, adult, pool1	10033-101E6	77.72	14.72	9.12	1.12	1.38	0.17	0.17
postcentral gyrus, adult, pool1	10032-101E5	78.02	11.16	11.51	0.78	1.05	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	217.51	43.92	10.46	0.00	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	5.51	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	95.41	20.68	10.05	0.58	1.31	3.79	0.00
prostate cancer cell line:PC-3	10439-106E7	145.56	33.40	8.17	0.73	2.18	0.54	0.00
prostate, adult, pool1	10022-101D4	96.22	7.71	7.98	2.81	0.82	0.73	1.36
putamen, adult, donor10196	10176-103C5	111.89	10.62	7.55	1.18	0.94	0.24	0.00
putamen, adult, donor10252	10152-102I8	39.21	1.96	7.84	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	78.68	5.46	3.28	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	64.75	9.42	3.87	0.97	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	54.73	7.50	6.00	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	127.72	8.15	10.18	0.29	2.91	0.00	0.00
rectum, fetal, donor1	10067-101I4	54.25	9.74	5.56	2.78	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	84.16	15.90	7.00	0.42	0.85	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	45.98	1.66	2.07	0.00	1.24	0.00	0.00
retina, adult, pool1	10030-101E3	105.36	15.80	11.83	1.79	0.80	1.49	0.50
retinoblastoma cell line:Y79	10475-106I7	127.04	0.78	13.51	0.00	1.04	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	156.88	13.16	19.43	0.49	2.46	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	317.19	12.65	16.59	0.56	9.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	106.10	40.17	5.30	9.09	1.52	0.76	1.52
salivary acinar cells, donor1	11771-123I7	73.97	27.03	7.12	2.75	0.81	2.43	0.81
salivary acinar cells, donor2	11772-123I8	64.16	25.89	8.12	8.12	0.83	7.16	1.24
salivary acinar cells, donor3	11773-123I9	82.09	23.17	8.61	39.72	0.00	9.27	7.94
salivary gland, adult, pool1	10093-102C3	151.00	12.58	12.58	0.00	1.14	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	81.44	21.67	6.74	1.26	0.76	0.51	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	77.35	20.92	5.64	1.88	1.06	0.59	0.35
seminal vesicle, adult	10201-103F3	151.84	22.22	11.64	0.53	1.06	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	200.17	23.56	7.29	2.19	4.86	3.40	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	67.69	10.32	8.05	0.25	0.50	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	135.48	16.06	12.04	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	118.34	10.88	10.61	1.48	2.69	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	133.74	1.99	5.19	0.22	1.55	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	116.64	26.06	13.16	4.26	1.68	1.16	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	265.29	3.55	11.35	7.09	3.55	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	292.53	9.48	15.95	2.28	6.48	3.72	0.48
skeletal muscle, fetal, donor1	10066-101I3	70.35	6.03	16.08	2.01	0.00	0.00	2.01
skin, adult, donor1	10074-102A2	61.07	0.00	13.57	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	110.46	16.41	8.21	6.94	1.26	9.47	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	175.77	3.67	11.67	0.67	1.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	135.85	7.25	16.08	0.00	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	121.82	0.39	14.07	0.19	2.70	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	201.58	3.46	11.70	0.33	4.45	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	157.95	3.70	16.08	0.16	4.50	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	169.54	28.77	28.33	2.83	0.65	0.00	0.00
small intestine, adult, pool1	10024-101D6	154.44	35.00	15.77	6.09	1.07	0.12	1.19
small intestine, fetal, donor1	10064-101I1	67.32	14.25	9.34	1.97	0.74	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	81.55	5.64	7.18	4.10	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	76.76	14.22	6.46	6.46	0.78	1.55	5.43
somatostatinoma cell line:QGP-1	10781-110G7	142.05	20.10	8.04	3.22	2.14	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	62.40	11.47	5.28	2.52	1.61	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	93.05	14.98	9.46	0.39	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	43.58	11.07	8.99	0.69	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	77.45	10.98	11.59	0.00	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	57.86	8.73	6.43	0.92	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	125.16	69.00	8.21	22.85	2.54	0.00	3.88
spleen, adult, pool1	10025-101D7	143.06	18.17	7.82	2.42	0.88	0.22	0.22
spleen, fetal, pool1	10044-101F8	131.50	18.12	11.76	3.97	1.03	0.32	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	134.36	1.86	10.45	0.10	2.59	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	134.24	16.14	5.89	2.09	4.94	0.38	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	222.60	32.50	26.91	6.64	2.10	15.38	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	206.80	8.21	10.56	1.56	5.47	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	259.22	15.08	11.03	1.80	3.71	1.01	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	213.50	19.49	16.94	1.69	4.24	2.12	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	181.50	21.58	26.23	1.69	3.38	0.00	0.00
stomach, fetal, donor1	10062-101H8	137.77	18.16	14.95	14.95	2.14	0.00	1.07
submaxillary gland, adult	10202-103F4	166.92	15.38	9.68	1.71	1.71	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	104.06	13.71	9.55	0.21	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	54.31	11.90	15.00	0.52	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	49.46	9.89	2.83	0.71	1.41	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	124.03	3.44	13.30	0.23	2.52	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	91.72	15.77	13.48	1.19	1.27	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	68.38	3.56	18.52	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	86.15	4.40	28.57	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	117.65	82.39	14.31	12.92	1.05	0.70	1.05
tenocyte, donor2	11765-123I1	58.37	30.90	5.72	4.58	0.76	0.38	1.53
tenocyte, donor3	11768-123I4	73.39	70.80	12.60	18.90	0.37	0.37	4.08
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	461.61	11.73	31.61	1.19	5.44	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	120.08	2.00	8.17	0.15	1.85	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	141.65	3.10	7.44	0.15	2.79	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	190.55	17.90	12.19	6.09	3.55	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	377.04	0.76	15.51	0.00	7.19	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	158.69	3.49	7.96	0.55	2.51	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	165.78	1.95	2.93	1.63	2.61	0.00	0.00
testis, adult, pool1	10026-101D8	104.26	23.62	7.30	4.19	1.40	0.54	1.29
testis, adult, pool2	10096-102C6	144.80	27.97	18.95	1.35	3.61	0.90	0.90
thalamus - adult, donor10196	10168-103B6	71.76	17.66	13.25	2.21	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	102.37	12.50	9.22	0.00	1.09	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	66.20	4.62	6.16	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	40.51	7.74	5.60	0.33	0.33	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	46.03	9.78	13.81	1.73	0.58	0.00	0.00
throat, adult	10209-103G2	125.08	15.23	12.23	9.99	1.75	7.49	1.75
throat, fetal, donor1	10061-101H7	76.18	9.14	8.23	2.74	0.00	3.05	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	144.88	38.16	20.07	1.99	1.59	0.00	0.60
thymus, adult, pool1	10027-101D9	137.39	3.88	5.67	0.40	1.09	1.09	0.00
thymus, fetal, pool1	10043-101F7	108.37	7.27	6.23	0.94	0.73	0.52	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	127.91	29.12	10.50	1.99	1.73	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	137.87	17.60	11.59	2.51	3.91	0.28	0.14
thyroid, adult, pool1	10028-101E1	147.25	19.04	6.44	1.59	2.15	6.25	0.47
thyroid, fetal, donor1	10060-101H6	97.03	16.08	6.86	1.58	1.32	2.37	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	135.50	6.16	6.16	9.24	6.16	3.08	3.08
tongue, adult	10203-103F5	133.50	16.75	14.19	16.28	1.16	13.49	1.86
tongue, fetal, donor1	10059-101H5	97.34	15.37	15.76	13.40	0.79	5.52	0.79
tonsil, adult, pool1	10047-101G2	169.10	17.03	13.42	10.32	1.00	9.82	1.10
trachea, adult, pool1	10029-101E2	158.61	15.62	9.16	5.64	1.64	3.03	1.23
trachea, fetal, donor1	10058-101H4	84.25	13.85	5.39	2.31	1.54	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	116.91	68.73	5.67	9.57	1.06	0.35	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	93.92	10.44	8.31	0.61	1.72	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	191.94	21.00	10.18	0.63	6.89	0.94	0.00
tridermal teratoma cell line:HGRT	10694-109G1	190.25	17.12	9.51	5.71	9.51	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	95.82	22.52	6.35	2.88	1.52	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	98.07	16.69	8.35	8.35	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	86.85	16.55	12.11	5.97	0.68	0.85	1.37
uterus, fetal, donor1	10055-101H1	71.67	11.26	6.14	4.10	1.02	5.12	0.51
vagina, adult	10204-103F6	75.61	5.17	7.75	0.65	0.65	0.00	0.65
vein, adult	10191-103E2	104.12	13.37	8.11	4.38	0.44	0.22	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	92.93	2.14	9.88	0.00	2.14	0.00	0.00